| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 1.45e-06 | 11 | 166 | 4 | GO:0098919 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 3.11e-06 | 13 | 166 | 4 | GO:0098879 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.32e-05 | 130 | 166 | 8 | GO:0005200 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KRT2 EPS8 CACNB2 ANK3 CLASP1 KIF26B MARK1 WASHC1 MTSS1 TOGARAM1 EPB41L4A PTPRT TTBK1 NDRG1 MAP1S TUBGCP3 PKD2 DLG1 DLEC1 PLEC CEP57 UTRN | 1.18e-04 | 1099 | 166 | 22 | GO:0008092 |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 1.38e-04 | 32 | 166 | 4 | GO:0099186 | |
| GeneOntologyMolecularFunction | gamma-tubulin binding | 2.73e-04 | 38 | 166 | 4 | GO:0043015 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 4.03e-04 | 42 | 166 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 4.42e-04 | 43 | 166 | 4 | GO:0030280 | |
| GeneOntologyMolecularFunction | structural molecule activity | SHANK1 FLG KRT2 DLGAP1 KRT6A KRT14 ANK3 LMNB2 FLG2 KRT76 AHNAK TUBGCP3 NPAP1 DLG1 MYOM2 PLEC CTNND2 GNL1 | 4.57e-04 | 891 | 166 | 18 | GO:0005198 |
| GeneOntologyMolecularFunction | SUMO polymer binding | 1.01e-03 | 6 | 166 | 2 | GO:0032184 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 1.04e-03 | 189 | 166 | 7 | GO:0004721 | |
| GeneOntologyBiologicalProcess | epithelium development | FLG KRT2 KRT6A RBM15 KRT14 ARHGAP24 FOXP2 CLASP1 KIF26B SIPA1L3 MTSS1 DVL1 DVL3 PUM2 CHD7 GATA5 HRNR FLG2 FOXI3 FOXA3 TULP3 NCOR1 CCM2 HEG1 KRT76 GLI2 PKD2 DLG1 ROBO1 PLEC WNK4 | 7.52e-07 | 1469 | 167 | 31 | GO:0060429 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | SHANK1 SLAIN2 KRT2 EPS8 KRT6A KRT8 KRT14 CLASP1 ADAMTS3 WASHC1 MTSS1 DVL1 TOGARAM1 CCDC57 KRT76 MAP1S ATXN7 TUBGCP3 DLG1 AKAP13 MYOM2 PLEC INPP5J | 2.96e-06 | 957 | 167 | 23 | GO:0097435 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | KRT6A RBM15 ARHGAP24 CLASP1 KIF26B MTSS1 DVL1 DVL3 CHD7 GATA5 FLG2 TULP3 CCM2 HEG1 GLI2 PKD2 DLG1 ROBO1 WNK4 | 1.11e-05 | 750 | 167 | 19 | GO:0048729 |
| GeneOntologyBiologicalProcess | cell junction organization | SHANK1 FILIP1 CACNB2 CACNB4 ANK3 CLASP1 MARK1 RIMS3 SARM1 MTSS1 DVL1 ARHGAP39 PTPRT PARD6B CCM2 HEG1 PTPRA NRXN2 DLG1 ROBO1 PLEC CTNND2 | 1.32e-05 | 974 | 167 | 22 | GO:0034330 |
| GeneOntologyBiologicalProcess | response to hydrostatic pressure | 1.78e-05 | 7 | 167 | 3 | GO:0051599 | |
| GeneOntologyBiologicalProcess | establishment of skin barrier | 1.94e-05 | 41 | 167 | 5 | GO:0061436 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | SLAIN2 CDC42BPA ANK3 CLASP1 MARK1 WASHC1 DVL1 TOGARAM1 CCDC57 PARD6B NCOR1 MAP1S ATXN7 RP1L1 TUBGCP3 PKD2 DLG1 INPP5J | 2.29e-05 | 720 | 167 | 18 | GO:0000226 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | KRT6A RBM15 ARHGAP24 CLASP1 KIF26B MTSS1 DVL1 DVL3 FLG2 TULP3 CCM2 GLI2 PKD2 DLG1 ROBO1 WNK4 | 4.50e-05 | 619 | 167 | 16 | GO:0002009 |
| GeneOntologyBiologicalProcess | microtubule-based process | SLAIN2 CDC42BPA ANK3 CLASP1 KIF26B MARK1 NEK10 WASHC1 BAG3 DVL1 TOGARAM1 CCDC57 PARD6B NCOR1 CELSR2 MAP1S ATXN7 RP1L1 TUBGCP3 PKD2 DLG1 INPP5J | 4.62e-05 | 1058 | 167 | 22 | GO:0007017 |
| GeneOntologyBiologicalProcess | skin development | FLG KRT2 KRT6A KRT14 PUM2 HRNR FLG2 FOXI3 NCOR1 KRT76 GLI2 PLEC | 5.45e-05 | 373 | 167 | 12 | GO:0043588 |
| GeneOntologyBiologicalProcess | regulation of p38MAPK cascade | 6.26e-05 | 52 | 167 | 5 | GO:1900744 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 6.37e-05 | 166 | 167 | 8 | GO:0098773 | |
| GeneOntologyBiologicalProcess | microtubule polymerization or depolymerization | 6.93e-05 | 168 | 167 | 8 | GO:0031109 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | EPS8 ARHGAP24 CDC42BPA SIPA1L3 RALGAPB RAP1GAP2 ARHGAP39 HEG1 ROBO1 AKAP13 TNS3 | 8.87e-05 | 333 | 167 | 11 | GO:0051056 |
| GeneOntologyBiologicalProcess | protein polymerization | SLAIN2 EPS8 CLASP1 WASHC1 MTSS1 TOGARAM1 CCDC57 TTBK1 TUBGCP3 DLG1 INPP5J | 9.11e-05 | 334 | 167 | 11 | GO:0051258 |
| GeneOntologyBiologicalProcess | epidermis development | FLG KRT2 KRT6A KRT14 PUM2 HRNR FLG2 FOXI3 TFDP1 NCOR1 KRT76 GLI2 PLEC | 1.01e-04 | 461 | 167 | 13 | GO:0008544 |
| GeneOntologyBiologicalProcess | inclusion body assembly | 1.41e-04 | 33 | 167 | 4 | GO:0070841 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | RBM15 KIF26B MTSS1 DVL1 DVL3 TULP3 CCM2 GLI2 PKD2 DLG1 ROBO1 WNK4 | 1.70e-04 | 421 | 167 | 12 | GO:0060562 |
| GeneOntologyBiologicalProcess | response to water | 1.78e-04 | 14 | 167 | 3 | GO:0009415 | |
| GeneOntologyBiologicalProcess | cellular response to hydrostatic pressure | 1.94e-04 | 3 | 167 | 2 | GO:0071464 | |
| GeneOntologyBiologicalProcess | cytoplasmic microtubule organization | 1.97e-04 | 66 | 167 | 5 | GO:0031122 | |
| GeneOntologyBiologicalProcess | p38MAPK cascade | 2.11e-04 | 67 | 167 | 5 | GO:0038066 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | SHANK1 SLAIN2 EPS8 CLASP1 WASHC1 MTSS1 TOGARAM1 MAP1S ATXN7 DLG1 AKAP13 INPP5J | 2.45e-04 | 438 | 167 | 12 | GO:1902903 |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transporter activity | 2.47e-04 | 256 | 167 | 9 | GO:0032412 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization or depolymerization | 2.49e-04 | 108 | 167 | 6 | GO:0031110 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 2.97e-04 | 321 | 167 | 10 | GO:0003007 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transporter activity | 3.28e-04 | 266 | 167 | 9 | GO:0022898 | |
| GeneOntologyBiologicalProcess | circadian regulation of gene expression | 3.58e-04 | 75 | 167 | 5 | GO:0032922 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 3.58e-04 | 75 | 167 | 5 | GO:0045109 | |
| GeneOntologyBiologicalProcess | organelle assembly | KRT8 CLASP1 TBC1D5 WASHC1 KIAA0586 BAG3 PUM2 MARCHF7 TOGARAM1 CCDC57 EVI5 NCOR1 CELSR2 NRXN2 RP1L1 TUBGCP3 CEP41 AKAP13 MYOM2 PLEC TNS3 | 3.58e-04 | 1138 | 167 | 21 | GO:0070925 |
| GeneOntologyBiologicalProcess | microtubule polymerization | 3.84e-04 | 117 | 167 | 6 | GO:0046785 | |
| GeneOntologyBiologicalProcess | synapse organization | SHANK1 FILIP1 CACNB2 CACNB4 ANK3 MARK1 RIMS3 SARM1 DVL1 ARHGAP39 PTPRT NRXN2 DLG1 ROBO1 CTNND2 | 4.68e-04 | 685 | 167 | 15 | GO:0050808 |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 5.27e-04 | 284 | 167 | 9 | GO:0009913 | |
| GeneOntologyCellularComponent | supramolecular fiber | SLAIN2 KRT2 KRT6A KRT8 KRT14 ANK3 CLASP1 KIF26B SARM1 BAG3 DVL1 TOGARAM1 LMNB2 CCDC57 SPECC1 CEP170 KRT76 NDRG1 MAP1S AHNAK RP1L1 TUBGCP3 DLG1 AKAP13 MYOM2 PLEC CEP57 | 7.21e-07 | 1179 | 167 | 27 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | SLAIN2 KRT2 KRT6A KRT8 KRT14 ANK3 CLASP1 KIF26B SARM1 BAG3 DVL1 TOGARAM1 LMNB2 CCDC57 SPECC1 CEP170 KRT76 NDRG1 MAP1S AHNAK RP1L1 TUBGCP3 DLG1 AKAP13 MYOM2 PLEC CEP57 | 8.22e-07 | 1187 | 167 | 27 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | SLAIN2 KRT2 KRT6A KRT8 KRT14 CLASP1 KIF26B SARM1 DVL1 TOGARAM1 LMNB2 CCDC57 SPECC1 CEP170 KRT76 NDRG1 MAP1S RP1L1 TUBGCP3 DLG1 AKAP13 PLEC CEP57 | 8.22e-07 | 899 | 167 | 23 | GO:0099513 |
| GeneOntologyCellularComponent | keratohyalin granule | 4.95e-06 | 5 | 167 | 3 | GO:0036457 | |
| GeneOntologyCellularComponent | microtubule organizing center | SLAIN2 CLASP1 WASHC1 KIAA0586 RAP1GAP2 MARCHF7 TOGARAM1 CCDC57 SPECC1 CEP170 EVI5 FBXL7 NDRG1 MAP1S KIAA1217 TUBGCP3 PKD2 CEP41 KNCN ZFYVE26 CEP57 | 1.45e-05 | 919 | 167 | 21 | GO:0005815 |
| GeneOntologyCellularComponent | costamere | 2.57e-05 | 22 | 167 | 4 | GO:0043034 | |
| GeneOntologyCellularComponent | cell-cell junction | KRT8 ARHGAP24 CDC42BPA ANK3 SIPA1L3 MTSS1 PARD6B HEG1 NDRG1 WTIP AHNAK PKD2 DLG1 CTNND2 WNK4 | 8.30e-05 | 591 | 167 | 15 | GO:0005911 |
| GeneOntologyCellularComponent | microtubule | SLAIN2 CLASP1 KIF26B SARM1 DVL1 TOGARAM1 CCDC57 CEP170 NDRG1 MAP1S RP1L1 TUBGCP3 DLG1 CEP57 | 1.01e-04 | 533 | 167 | 14 | GO:0005874 |
| GeneOntologyCellularComponent | centrosome | SLAIN2 CLASP1 WASHC1 KIAA0586 RAP1GAP2 MARCHF7 CCDC57 CEP170 EVI5 FBXL7 NDRG1 MAP1S KIAA1217 TUBGCP3 CEP41 ZFYVE26 CEP57 | 1.51e-04 | 770 | 167 | 17 | GO:0005813 |
| GeneOntologyCellularComponent | cornified envelope | 2.28e-04 | 69 | 167 | 5 | GO:0001533 | |
| GeneOntologyCellularComponent | anchoring junction | KRT8 ARHGAP24 CDC42BPA ANK3 CLASP1 SIPA1L3 MTSS1 PARD6B HEG1 PTPRA NDRG1 WTIP AHNAK PKD2 DLG1 PLEC CTNND2 WNK4 TNS3 | 3.07e-04 | 976 | 167 | 19 | GO:0070161 |
| GeneOntologyCellularComponent | sarcolemma | 8.55e-04 | 190 | 167 | 7 | GO:0042383 | |
| GeneOntologyCellularComponent | keratin filament | 1.09e-03 | 97 | 167 | 5 | GO:0045095 | |
| GeneOntologyCellularComponent | basal cortex | 1.30e-03 | 7 | 167 | 2 | GO:0045180 | |
| HumanPheno | Micropenis | KIAA0586 DVL1 DVL3 TOGARAM1 CHD7 LMNB2 HUWE1 PIEZO2 GLI2 RLIM NPAP1 CEP41 LSM11 | 1.77e-05 | 278 | 61 | 13 | HP:0000054 |
| HumanPheno | Onychogryposis | 1.99e-05 | 29 | 61 | 5 | HP:0001805 | |
| Domain | Dishevelled | 2.64e-06 | 4 | 164 | 3 | PF02377 | |
| Domain | Dishevelled_fam | 2.64e-06 | 4 | 164 | 3 | IPR008339 | |
| Domain | Dishevelled_protein_dom | 2.64e-06 | 4 | 164 | 3 | IPR003351 | |
| Domain | Intermediate_filament_CS | 1.88e-05 | 63 | 164 | 6 | IPR018039 | |
| Domain | DIX | 2.27e-05 | 7 | 164 | 3 | PF00778 | |
| Domain | DIX | 2.27e-05 | 7 | 164 | 3 | IPR001158 | |
| Domain | DIX | 2.27e-05 | 7 | 164 | 3 | PS50841 | |
| Domain | DAX | 2.27e-05 | 7 | 164 | 3 | SM00021 | |
| Domain | PDZ | 3.51e-05 | 141 | 164 | 8 | PF00595 | |
| Domain | Filament | 3.74e-05 | 71 | 164 | 6 | SM01391 | |
| Domain | IF | 4.05e-05 | 72 | 164 | 6 | PS00226 | |
| Domain | Filament | 4.38e-05 | 73 | 164 | 6 | PF00038 | |
| Domain | PDZ | 4.95e-05 | 148 | 164 | 8 | SM00228 | |
| Domain | Keratin_2_head | 5.31e-05 | 24 | 164 | 4 | IPR032444 | |
| Domain | Keratin_2_head | 5.31e-05 | 24 | 164 | 4 | PF16208 | |
| Domain | IF | 5.50e-05 | 76 | 164 | 6 | IPR001664 | |
| Domain | PDZ | 5.71e-05 | 151 | 164 | 8 | PS50106 | |
| Domain | PDZ | 5.98e-05 | 152 | 164 | 8 | IPR001478 | |
| Domain | Keratin_II | 7.37e-05 | 26 | 164 | 4 | IPR003054 | |
| Domain | Pumilio_RNA-bd | 7.66e-05 | 2 | 164 | 2 | IPR033712 | |
| Domain | DVL-1 | 7.66e-05 | 2 | 164 | 2 | IPR008340 | |
| Domain | Filaggrin | 7.66e-05 | 2 | 164 | 2 | IPR003303 | |
| Domain | Rap_GAP_dom | 1.04e-04 | 11 | 164 | 3 | IPR000331 | |
| Domain | RAPGAP | 1.04e-04 | 11 | 164 | 3 | PS50085 | |
| Domain | - | EPS8 ARHGAP24 CDC42BPA EPB41L4A OSBP CCM2 MTMR4 SBF1 OSBPL10 AKAP13 TNS3 FAM43A | 1.80e-04 | 391 | 164 | 12 | 2.30.29.30 |
| Domain | PUF | 2.29e-04 | 3 | 164 | 2 | PF00806 | |
| Domain | PUM_HD | 2.29e-04 | 3 | 164 | 2 | PS50303 | |
| Domain | Dishevelled_C-dom | 2.29e-04 | 3 | 164 | 2 | IPR024580 | |
| Domain | PUM-HD | 2.29e-04 | 3 | 164 | 2 | IPR033133 | |
| Domain | Dsh_C | 2.29e-04 | 3 | 164 | 2 | PF12316 | |
| Domain | - | 3.64e-04 | 150 | 164 | 7 | 2.30.42.10 | |
| Domain | PH_dom-like | EPS8 ARHGAP24 CDC42BPA EPB41L4A OSBP CCM2 MTMR4 SBF1 OSBPL10 AKAP13 TNS3 FAM43A | 3.93e-04 | 426 | 164 | 12 | IPR011993 |
| Domain | PTB/PI_dom | 4.51e-04 | 41 | 164 | 4 | IPR006020 | |
| Domain | VDCC_L_bsu | 4.55e-04 | 4 | 164 | 2 | IPR000584 | |
| Domain | PUM | 4.55e-04 | 4 | 164 | 2 | PS50302 | |
| Domain | Dsh/Dvl-rel | 4.55e-04 | 4 | 164 | 2 | IPR015506 | |
| Domain | Pumilio_RNA-bd_rpt | 4.55e-04 | 4 | 164 | 2 | IPR001313 | |
| Domain | VGCC_beta4Aa_N | 4.55e-04 | 4 | 164 | 2 | PF12052 | |
| Domain | Pumilio | 4.55e-04 | 4 | 164 | 2 | SM00025 | |
| Domain | WW | 7.62e-04 | 47 | 164 | 4 | PF00397 | |
| Domain | WW | 8.25e-04 | 48 | 164 | 4 | SM00456 | |
| Domain | ARM-type_fold | CLASP1 NEK10 SARM1 PUM2 TOGARAM1 CTIF HUWE1 PDCD4 CTNND2 PUM1 | 8.46e-04 | 339 | 164 | 10 | IPR016024 |
| Domain | DEP | 9.05e-04 | 22 | 164 | 3 | PF00610 | |
| Domain | DEP | 9.05e-04 | 22 | 164 | 3 | PS50186 | |
| Domain | EPHD | 9.05e-04 | 22 | 164 | 3 | PS51805 | |
| Domain | DEP | 9.05e-04 | 22 | 164 | 3 | SM00049 | |
| Domain | DEP_dom | 1.03e-03 | 23 | 164 | 3 | IPR000591 | |
| Domain | WW_DOMAIN_1 | 1.04e-03 | 51 | 164 | 4 | PS01159 | |
| Domain | WW_DOMAIN_2 | 1.04e-03 | 51 | 164 | 4 | PS50020 | |
| Domain | WW_dom | 1.12e-03 | 52 | 164 | 4 | IPR001202 | |
| Domain | WH2 | 1.17e-03 | 24 | 164 | 3 | PS51082 | |
| Domain | Guanylate_kin | 1.49e-03 | 26 | 164 | 3 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 1.49e-03 | 26 | 164 | 3 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 1.49e-03 | 26 | 164 | 3 | IPR008144 | |
| Domain | GuKc | 1.49e-03 | 26 | 164 | 3 | SM00072 | |
| Domain | S100_CABP | 1.67e-03 | 27 | 164 | 3 | PS00303 | |
| Domain | S_100 | 1.67e-03 | 27 | 164 | 3 | PF01023 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.81e-03 | 99 | 164 | 5 | IPR029021 | |
| Domain | S100_Ca-bd_sub | 1.85e-03 | 28 | 164 | 3 | IPR013787 | |
| Domain | S100/CaBP-9k_CS | 1.85e-03 | 28 | 164 | 3 | IPR001751 | |
| Domain | S_100 | 1.85e-03 | 28 | 164 | 3 | SM01394 | |
| Domain | PTB | 2.07e-03 | 8 | 164 | 2 | IPR013625 | |
| Domain | PTB | 2.07e-03 | 8 | 164 | 2 | PF08416 | |
| Domain | CH | 2.56e-03 | 65 | 164 | 4 | SM00033 | |
| Domain | ARM-like | 2.70e-03 | 270 | 164 | 8 | IPR011989 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SLAIN2 RBM15 KRT8 CDC42BPA TCF20 SASH1 CLASP1 KIF26B TBC1D5 SIPA1L3 MINK1 BAG3 RALGAPB SPECC1 CEP170 WWC2 MTMR4 NDRG1 SBF1 AHNAK KIAA1217 EIF4B NAV2 OSBPL10 KMT2A AKAP13 TAB1 PLEC MORC3 PUM1 UTRN WNK4 TNS3 | 3.61e-20 | 861 | 170 | 33 | 36931259 |
| Pubmed | SHANK1 DLGAP1 CACNB2 CACNB4 ARHGAP24 TCF20 ANK3 FOXP2 CLASP1 TBC1D5 SIPA1L3 MINK1 CHD7 LMNB2 ARHGAP39 HUWE1 UBN2 MAP3K5 CEP170 NCOR1 CELSR2 SBF1 WTIP KIAA1217 DLG1 CTNND2 MGA AFF4 RAI1 LRRFIP2 SMG6 | 7.57e-17 | 963 | 170 | 31 | 28671696 | |
| Pubmed | SHANK1 DLGAP1 KRT8 KRT14 CDC42BPA TCF20 ANK3 KIF26B CCDC186 BAG3 RAP1GAP2 MUC12 MAP3K5 PARD6B NAV2 ROBO1 AKAP13 WASH2P PLEC MGA RNF111 | 4.02e-14 | 486 | 170 | 21 | 20936779 | |
| Pubmed | USP36 KRT2 RBM15 KRT8 KRT14 CDC42BPA ANK3 CDKN2AIP TBC1D5 SIPA1L3 MINK1 BAG3 RALGAPB ARHGAP39 HUWE1 PTPRT TULP3 NCOR1 WWC2 MTMR4 PTPRA SBF1 AHNAK DLG1 ROBO1 TAB1 PUM1 UTRN TNS3 | 4.11e-14 | 1049 | 170 | 29 | 27880917 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | USP36 RBM15 KRT8 ANK3 CLASP1 ZC3H13 SIPA1L3 BAG3 TOGARAM1 CEP170 MAP1S ASXL3 EIF4B SERPING1 AKAP13 CTNND2 TNS3 FAM43A | 2.65e-13 | 361 | 170 | 18 | 26167880 |
| Pubmed | SHANK1 KRT2 EPS8 DLGAP1 KRT6A CACNB2 PDE1C CACNB4 KRT14 ANK3 CLASP1 MARK1 SIPA1L3 MINK1 ARHGAP39 SPECC1 CEP170 KRT76 PTPRA MAP1S SBF1 NRXN2 KIAA1217 EIF4B OSBPL10 KMT2A DLG1 DDX3Y PLEC CTNND2 UTRN LRRFIP2 | 5.36e-13 | 1431 | 170 | 32 | 37142655 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FILIP1 RBM15 TCF20 CLASP1 ZC3H13 MINK1 BAG3 RALGAPB PUM2 CHD7 ARHGAP39 HUWE1 NCOR1 WWC2 OSBP NDRG1 GTF3C1 MAP1S ATXN7 EIF4B KMT2A DLG1 PLEC | 5.33e-12 | 774 | 170 | 23 | 15302935 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | FLG KRT2 KRT6A RBM15 KRT8 KRT14 CDC42BPA TCF20 CLASP1 MARK1 ZC3H13 CHD7 LMNB2 ARHGAP39 HRNR FLG2 CEP170 GTF3C1 SBF1 NRXN2 TUBGCP3 SEC61B DDX3Y PLEC SF3A2 AFF4 | 2.21e-11 | 1082 | 170 | 26 | 38697112 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | SLAIN2 ZSWIM8 CLASP1 CDKN2AIP TBC1D5 DVL1 DVL3 PER1 RAP1GAP2 MARCHF7 PDCD4 CEP170 WWC2 SLC7A6OS KIAA1217 EIF4B TUBGCP3 CEP41 LSM11 TAB1 PUM1 ANKS3 TNS3 FAM83A | 3.05e-10 | 1038 | 170 | 24 | 26673895 |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | KRT2 PDE1C SRRM4 MUC16 HRNR PTPRT SLC45A4 CEP170 WWC2 PTPRA SBF1 KIAA1217 EIF4B RLIM TAB1 TNS3 | 3.18e-10 | 420 | 170 | 16 | 28065597 |
| Pubmed | EPS8 CACNB2 SASH1 ANK3 MARK1 MINK1 RALGAPB SPECC1 PARD6B CELSR2 SBF1 KIAA1217 OSBPL10 DLG1 ROBO1 UTRN | 3.29e-10 | 421 | 170 | 16 | 36976175 | |
| Pubmed | SLAIN2 RBM15 ARHGAP24 CDC42BPA BAG3 LMNB2 ARHGAP39 HUWE1 CEP170 AHNAK SEC61B KMT2A DLG1 ROBO1 AKAP13 LSM11 TAB1 PLEC MGA UTRN SF3A2 SORL1 | 8.90e-10 | 916 | 170 | 22 | 32203420 | |
| Pubmed | SHANK1 PCNP DLGAP1 CACNB4 CDC42BPA ANK3 MARK1 MINK1 DVL1 DVL3 PER1 ARHGAP39 HUWE1 CEP170 OSBP NDRG1 CELSR2 MAP1S KIAA1217 EIF4B DLG1 TAB1 PLEC CTNND2 | 1.91e-09 | 1139 | 170 | 24 | 36417873 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CACNB2 CDC42BPA ANK3 TBC1D5 SIPA1L3 MINK1 RALGAPB CTIF ARHGAP39 HUWE1 UBN2 CCDC57 TULP3 CEP170 NDRG1 GTF3C1 ATXN7 GLI2 KIAA1217 PKD2 DLG1 AKAP13 UTRN AFF4 RAI1 SMG6 FAM149A | 4.23e-09 | 1489 | 170 | 27 | 28611215 |
| Pubmed | USP36 PCNP SLAIN2 EPS8 CDC42BPA CLASP1 CDKN2AIP SIPA1L3 MINK1 RALGAPB PUM2 CHD7 ARHGAP39 UBN2 SPECC1 PARD6B SBF1 ATXN7 EIF4B KMT2A DLG1 LSM11 CTNND2 UTRN SF3A2 AFF4 SMG6 | 4.74e-09 | 1497 | 170 | 27 | 31527615 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CDC42BPA PPRC1 SIPA1L3 DVL1 PER1 RAP1GAP2 LMNB2 HUWE1 MAP3K5 NCOR1 HEG1 CELSR2 MAP1S SBF1 AHNAK NAV2 AKAP13 ZFYVE26 PLEC PUM1 RAI1 SMG6 BAHCC1 | 5.40e-09 | 1105 | 170 | 23 | 35748872 |
| Pubmed | PCNP SLAIN2 TCF20 ANK3 BAG3 DVL1 HUWE1 UBN2 CEP170 NCOR1 GTF3C1 AHNAK KMT2A DLG1 TAB1 MGA | 1.44e-08 | 549 | 170 | 16 | 38280479 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TCF20 FOXP2 CHD7 HRNR FLG2 UBN2 TFDP1 NCOR1 ASXL3 KMT2A MGA RAI1 BAHCC1 | 2.16e-08 | 351 | 170 | 13 | 38297188 |
| Pubmed | MARK1 SIPA1L3 KIAA0586 SARM1 PER1 TOGARAM1 CTIF ARHGAP39 UBN2 SEMA4G SLC45A4 CEP170 TTBK1 MORC3 MGA | 2.36e-08 | 493 | 170 | 15 | 15368895 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ANK3 TBC1D5 CHD7 HRNR LDLRAD3 TULP3 NCOR1 KRT76 MAP1S GLI2 AKAP13 PLEC MGA WNK4 | 3.06e-08 | 430 | 170 | 14 | 35044719 |
| Pubmed | FLG KRT2 KRT6A KRT14 CDKN2AIP HRNR FLG2 AHNAK EIF4B TAB1 SF3A2 | 3.91e-08 | 245 | 170 | 11 | 35652658 | |
| Pubmed | FLG KRT2 KRT6A KRT8 KRT14 PPRC1 SIPA1L3 LMNB2 CCDC57 NCOR1 KRT76 GTF3C1 ATXN7 AHNAK EIF4B NAV2 KMT2A DLG1 DLEC1 MYOM2 PLEC CEP57 SF3A2 RAI1 BAHCC1 | 4.05e-08 | 1442 | 170 | 25 | 35575683 | |
| Pubmed | USP36 SLAIN2 KRT2 KRT14 CDC42BPA ANK3 CCDC186 MINK1 MUC16 HUWE1 HRNR FLG2 NCOR1 AHNAK OSBPL10 DLG1 ROBO1 MGA | 5.76e-08 | 777 | 170 | 18 | 35844135 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | PCNP KRT8 KIF26B DVL1 DVL3 CEP170 AHNAK EIF4B DLG1 ROBO1 PLEC | 6.11e-08 | 256 | 170 | 11 | 33397691 |
| Pubmed | PCNP CACNB2 ANK3 PPRC1 MARK1 ZC3H13 MARCHF7 CHD7 HUWE1 UBN2 WWC2 EIF4B RLIM DLG1 DDX3Y PLEC PUM1 MGA UTRN QSOX2 AFF4 | 8.84e-08 | 1084 | 170 | 21 | 11544199 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | USP36 PCNP KRT6A MINK1 DVL1 DVL3 PUM2 UBN2 CEP170 SBF1 AHNAK EIF4B AKAP13 PLEC PUM1 MGA TNS3 | 1.14e-07 | 724 | 170 | 17 | 36232890 |
| Pubmed | Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. | 1.15e-07 | 3 | 170 | 3 | 23403047 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CDC42BPA CLASP1 MARK1 CCDC186 MINK1 SPECC1 CEP170 GTF3C1 MAP1S KMT2A TAB1 PLEC SH2D1A GNL1 UTRN AFF4 TNS3 FAM83A RNF111 | 1.22e-07 | 910 | 170 | 19 | 36736316 |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | DLGAP1 SIPA1L3 DVL1 CTIF ARHGAP39 WWC2 SNCAIP TAB1 CTNND2 SMG6 | 1.35e-07 | 218 | 170 | 10 | 33378226 |
| Pubmed | ZSWIM8 RBM15 TCF20 ZC3H13 CHD7 LMNB2 HUWE1 CEP170 GTF3C1 SBF1 AHNAK KMT2A PLEC PUM1 UTRN RAI1 | 1.54e-07 | 653 | 170 | 16 | 22586326 | |
| Pubmed | TCF20 BAG3 DVL1 DVL3 CHD7 HUWE1 TFDP1 NCOR1 GTF3C1 AHNAK PLEC MGA UTRN | 1.64e-07 | 418 | 170 | 13 | 34709266 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | RBM15 ANK3 CLASP1 CDKN2AIP CCDC57 GTF3C1 MAP1S EIF4B NAV2 KMT2A MYOM2 PUM1 WNK4 RAI1 | 1.81e-07 | 497 | 170 | 14 | 36774506 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT2 KRT6A RBM15 KRT8 KRT14 ZC3H13 SIPA1L3 BTBD10 LMNB2 HRNR FLG2 SPECC1 PDCD4 CEP170 GTF3C1 AHNAK KIAA1217 EIF4B DLG1 PLEC SF3A2 LRRFIP2 | 2.44e-07 | 1257 | 170 | 22 | 36526897 |
| Pubmed | SLAIN2 KRT2 KRT6A KRT14 CDKN2AIP BAG3 HRNR AHNAK TUBGCP3 CDADC1 TAB1 | 2.81e-07 | 298 | 170 | 11 | 30737378 | |
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | 3.38e-07 | 91 | 170 | 7 | 34445801 | |
| Pubmed | SHANK1 ZSWIM8 DLGAP1 ANK3 PPRC1 SIPA1L3 DVL3 RAP1GAP2 HUWE1 SPECC1 PTPRA NDRG1 MAP1S DLG1 ROBO1 PLEC MORC3 CTNND2 UTRN SF3A2 AFF4 RNF111 | 3.54e-07 | 1285 | 170 | 22 | 35914814 | |
| Pubmed | USP36 SLAIN2 CDC42BPA SASH1 SRRM4 MTSS1 FBXL7 SBF1 NRXN2 NAV2 CEP57 ANKS3 RAI1 SMG6 | 3.82e-07 | 529 | 170 | 14 | 14621295 | |
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 24643799 | ||
| Pubmed | 4.57e-07 | 4 | 170 | 3 | 8817329 | ||
| Pubmed | Human dishevelled genes constitute a DHR-containing multigene family. | 4.57e-07 | 4 | 170 | 3 | 9192851 | |
| Pubmed | ZSWIM8 CACNB2 DVL1 UBN2 SEMA4G TFDP1 NCOR1 OSBP MTMR4 NDRG1 NRXN2 RP1L1 KMT2A ROBO1 ZFYVE26 PLEC ROBO3 PUM1 ANKS3 | 5.57e-07 | 1006 | 170 | 19 | 15226823 | |
| Pubmed | 6.01e-07 | 197 | 170 | 9 | 36604605 | ||
| Pubmed | 6.56e-07 | 146 | 170 | 8 | 21399614 | ||
| Pubmed | The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability. | KRT2 KRT6A KRT8 LMNB2 SPECC1 CEP170 EIF4B PLEC SF3A2 QSOX2 LRRFIP2 | 7.24e-07 | 328 | 170 | 11 | 23398456 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | USP36 FLG RBM15 ZC3H13 BAG3 LMNB2 HUWE1 FLG2 SPECC1 AHNAK EIF4B SEC61B PLEC | 7.29e-07 | 477 | 170 | 13 | 31300519 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ANK3 SIPA1L3 MINK1 BAG3 DVL3 SPECC1 NDRG1 AHNAK KIAA1217 EIF4B NAV2 DLG1 PLEC UTRN | 8.35e-07 | 565 | 170 | 14 | 25468996 |
| Pubmed | RBM15 CDC42BPA WWC3 SIPA1L3 BAG3 DVL1 DVL3 HUWE1 SPECC1 PDCD4 NCOR1 NDRG1 EIF4B SEC61B DLG1 DDX3Y MGA SF3A2 AFF4 TNS3 LRRFIP2 | 8.70e-07 | 1247 | 170 | 21 | 27684187 | |
| Pubmed | FLG KRT2 KRT6A KRT8 KRT14 FLG2 SPECC1 AHNAK DLG1 DDX3Y PLEC PUM1 TNS3 | 9.40e-07 | 488 | 170 | 13 | 31324722 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | USP36 RBM15 TCF20 CDKN2AIP ZC3H13 CHD7 UBN2 CEP170 NCOR1 AHNAK EIF4B SEC61B KMT2A DDX3Y PUM1 MGA AFF4 RAI1 | 1.14e-06 | 954 | 170 | 18 | 36373674 |
| Pubmed | ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1. | 1.47e-06 | 113 | 170 | 7 | 34474245 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | KRT2 KRT6A KRT8 KRT14 HRNR CEP170 EIF4B TAB1 PLEC MGA LRRFIP2 | 1.48e-06 | 353 | 170 | 11 | 27545878 |
| Pubmed | 1.81e-06 | 225 | 170 | 9 | 12168954 | ||
| Pubmed | 1.90e-06 | 75 | 170 | 6 | 31527668 | ||
| Pubmed | Proteome-wide analysis of phospho-regulated PDZ domain interactions. | 1.93e-06 | 42 | 170 | 5 | 30126976 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | PCNP SLAIN2 CDKN2AIP TBC1D5 UBN2 CEP170 NCOR1 ATXN7 AHNAK EIF4B TAB1 MGA | 2.15e-06 | 444 | 170 | 12 | 34795231 |
| Pubmed | EPS8 RBM15 CLASP1 MARK1 TBC1D5 SIPA1L3 RALGAPB CEP170 MAP1S TAB1 PUM1 UTRN | 2.25e-06 | 446 | 170 | 12 | 24255178 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | CDC42BPA SASH1 ANK3 KIF26B MINK1 TULP3 PTPRA NDRG1 DLG1 ROBO1 UTRN | 2.79e-06 | 377 | 170 | 11 | 38117590 |
| Pubmed | TBC1D5 ZC3H13 WASHC1 DVL3 ARHGAP39 EVI5 SBF1 EIF4B TAB1 MGA LRRFIP2 | 2.86e-06 | 378 | 170 | 11 | 34315543 | |
| Pubmed | 3.39e-06 | 128 | 170 | 7 | 30995482 | ||
| Pubmed | TCF20 CLASP1 PUM2 CHD7 LMNB2 HUWE1 CEP170 MTMR4 SEC61B DLG1 ROBO1 AKAP13 PUM1 MGA TNS3 | 3.54e-06 | 733 | 170 | 15 | 34672954 | |
| Pubmed | PCNP SLAIN2 RBM15 CDKN2AIP ZC3H13 HUWE1 PDCD4 CEP170 EIF4B LSM11 TAB1 PLEC MGA | 3.56e-06 | 551 | 170 | 13 | 34728620 | |
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 3.70e-06 | 84 | 170 | 6 | 29563501 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | SLAIN2 FLG KRT2 KRT6A KRT8 KRT14 HRNR FLG2 AHNAK EIF4B TAB1 PLEC MGA | 4.08e-06 | 558 | 170 | 13 | 27591049 |
| Pubmed | 4.42e-06 | 251 | 170 | 9 | 27507650 | ||
| Pubmed | 4.90e-06 | 191 | 170 | 8 | 33762435 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | SLAIN2 EPS8 KRT8 TBC1D5 SIPA1L3 CTIF CCDC57 NCOR1 NDRG1 KIAA1217 EIF4B CEP41 TAB1 PLEC MORC3 MGA | 5.00e-06 | 853 | 170 | 16 | 28718761 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | EPS8 CDC42BPA TBC1D5 MINK1 SPECC1 TULP3 PIEZO2 PTPRA CELSR2 NAV2 OSBPL10 DLG1 TNS3 | 5.04e-06 | 569 | 170 | 13 | 30639242 |
| Pubmed | Identification of trichoplein, a novel keratin filament-binding protein. | 6.31e-06 | 8 | 170 | 3 | 15731013 | |
| Pubmed | 6.31e-06 | 8 | 170 | 3 | 24717433 | ||
| Pubmed | 6.54e-06 | 335 | 170 | 10 | 15741177 | ||
| Pubmed | SLAIN2 CDC42BPA TULP3 MAP3K5 CEP170 NCOR1 EIF4B TUBGCP3 MYOM2 PLEC MGA UTRN | 6.77e-06 | 497 | 170 | 12 | 23414517 | |
| Pubmed | 6.85e-06 | 54 | 170 | 5 | 35474131 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | EPS8 ZSWIM8 RBM15 KRT14 CLASP1 CHD7 HUWE1 UBN2 NCOR1 KIAA1217 MORC3 ZMYM6 SORL1 | 7.16e-06 | 588 | 170 | 13 | 38580884 |
| Pubmed | RBM15 KRT8 ZC3H13 BAG3 HUWE1 PDCD4 NCOR1 NDRG1 GTF3C1 NAV2 AKAP13 ANKS3 | 7.63e-06 | 503 | 170 | 12 | 16964243 | |
| Pubmed | 8.97e-06 | 57 | 170 | 5 | 31862882 | ||
| Pubmed | Type II keratins precede type I keratins during early embryonic development. | 9.43e-06 | 9 | 170 | 3 | 16180309 | |
| Pubmed | Hedgehog signaling regulates FOXA2 in esophageal embryogenesis and Barrett's metaplasia. | 9.43e-06 | 9 | 170 | 3 | 25083987 | |
| Pubmed | 1.10e-05 | 281 | 170 | 9 | 24163370 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.10e-05 | 281 | 170 | 9 | 28706196 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.17e-05 | 358 | 170 | 10 | 32460013 | |
| Pubmed | The insulin receptor substrate of 53 kDa (IRSp53) limits hippocampal synaptic plasticity. | 1.19e-05 | 29 | 170 | 4 | 19208628 | |
| Pubmed | KRT6A RBM15 KRT8 LMNB2 CEP170 SNCAIP AHNAK KIAA1217 PLEC UTRN | 1.22e-05 | 360 | 170 | 10 | 33111431 | |
| Pubmed | 1.34e-05 | 10 | 170 | 3 | 24940650 | ||
| Pubmed | PCNP KRT6A RBM15 CDC42BPA CLASP1 SIPA1L3 CHD7 FLG2 CEP170 PARD6B AHNAK TUBGCP3 SEC61B KMT2A DDX3Y PLEC PIPSL GNL1 AFF4 LRRFIP2 | 1.35e-05 | 1371 | 170 | 20 | 36244648 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | EPS8 CLASP1 SIPA1L3 MINK1 CHD7 NCOR1 GLI2 KIAA1217 EIF4B DLG1 PUM1 SMG6 | 1.44e-05 | 536 | 170 | 12 | 15840001 |
| Pubmed | 1.47e-05 | 63 | 170 | 5 | 16831889 | ||
| Pubmed | EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions. | 1.47e-05 | 63 | 170 | 5 | 29162697 | |
| Pubmed | EPS8 CLASP1 SIPA1L3 MINK1 CHD7 NCOR1 GLI2 KIAA1217 EIF4B DLG1 PUM1 SMG6 | 1.49e-05 | 538 | 170 | 12 | 10512203 | |
| Pubmed | 1.84e-05 | 11 | 170 | 3 | 18809727 | ||
| Pubmed | 1.93e-05 | 167 | 170 | 7 | 25659891 | ||
| Pubmed | Biological insights from 108 schizophrenia-associated genetic loci. | 1.99e-05 | 303 | 170 | 9 | 25056061 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 2.01e-05 | 232 | 170 | 8 | 25515538 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 12954649 | ||
| Pubmed | Mucins: a biologically relevant glycan barrier in mucosal protection. | 2.38e-05 | 2 | 170 | 2 | 24821013 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 27939686 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 12652298 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 12459267 | ||
| Pubmed | Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins. | 2.38e-05 | 2 | 170 | 2 | 29165587 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 35507203 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 9344861 | ||
| Interaction | YWHAH interactions | SLAIN2 DLGAP1 RBM15 KRT8 CDC42BPA TCF20 SASH1 CLASP1 KIF26B MARK1 TBC1D5 ZC3H13 SIPA1L3 MINK1 BAG3 RALGAPB HUWE1 SPECC1 PDCD4 MAP3K5 CEP170 PARD6B WWC2 MTMR4 SNCAIP NDRG1 SBF1 AHNAK KIAA1217 EIF4B NAV2 OSBPL10 KMT2A AKAP13 TAB1 PLEC MORC3 PUM1 UTRN TNS3 | 9.79e-16 | 1102 | 166 | 40 | int:YWHAH |
| Interaction | YWHAG interactions | SLAIN2 DLGAP1 RBM15 KRT8 CDC42BPA SASH1 CLASP1 KIF26B MARK1 TBC1D5 ZC3H13 SIPA1L3 RIMS3 MINK1 BAG3 RALGAPB HUWE1 SPECC1 PDCD4 MAP3K5 CEP170 PARD6B WWC2 MTMR4 TTBK1 NDRG1 SBF1 EIF4B NAV2 OSBPL10 KMT2A AKAP13 TAB1 MORC3 PUM1 UTRN TNS3 | 6.53e-12 | 1248 | 166 | 37 | int:YWHAG |
| Interaction | YWHAZ interactions | DLGAP1 RBM15 KRT8 CDC42BPA SASH1 CLASP1 KIF26B MARK1 TBC1D5 SIPA1L3 RIMS3 MINK1 BAG3 RALGAPB RAP1GAP2 HUWE1 HRNR SPECC1 MAP3K5 CEP170 PARD6B NCOR1 WWC2 MTMR4 PTPRA SBF1 ASXL3 EIF4B NAV2 KMT2A AKAP13 TAB1 PLEC MORC3 PUM1 | 5.53e-10 | 1319 | 166 | 35 | int:YWHAZ |
| Interaction | YWHAE interactions | DLGAP1 RBM15 KRT8 CDC42BPA SASH1 CLASP1 KIF26B MARK1 TBC1D5 SIPA1L3 RIMS3 MINK1 BAG3 RALGAPB RAP1GAP2 HUWE1 SPECC1 PDCD4 MAP3K5 CEP170 PARD6B WWC2 MTMR4 SBF1 EIF4B NAV2 KMT2A AKAP13 TAB1 MORC3 PUM1 MGA CEP57 LRRFIP2 | 6.12e-10 | 1256 | 166 | 34 | int:YWHAE |
| Interaction | SFN interactions | KRT2 KRT8 CDC42BPA SASH1 CLASP1 KIF26B MARK1 TBC1D5 SIPA1L3 MINK1 SPECC1 MAP3K5 CEP170 WWC2 OSBP MTMR4 EIF4B NAV2 KMT2A AKAP13 TAB1 PLEC PUM1 TNS3 | 2.66e-09 | 692 | 166 | 24 | int:SFN |
| Interaction | YWHAQ interactions | DLGAP1 KRT8 CDC42BPA SASH1 CLASP1 KIF26B MARK1 TBC1D5 ZC3H13 SIPA1L3 MINK1 BAG3 SPECC1 PDCD4 MAP3K5 CEP170 PARD6B WWC2 MTMR4 SBF1 EIF4B TUBGCP3 NAV2 KMT2A AKAP13 TAB1 PLEC PUM1 WNK4 TNS3 | 9.11e-09 | 1118 | 166 | 30 | int:YWHAQ |
| Interaction | YWHAB interactions | SLAIN2 DLGAP1 KRT8 CDC42BPA SASH1 CLASP1 KIF26B MARK1 TBC1D5 SIPA1L3 MINK1 BAG3 RALGAPB SPECC1 MAP3K5 CEP170 PARD6B WWC2 OSBP MTMR4 EIF4B NAV2 KMT2A AKAP13 TAB1 MORC3 PUM1 TNS3 | 1.67e-08 | 1014 | 166 | 28 | int:YWHAB |
| Interaction | MAPRE3 interactions | SLAIN2 FILIP1 CLASP1 SIPA1L3 MINK1 DVL1 MARCHF7 SPECC1 CEP170 TTBK1 MAP1S KIAA1217 NAV2 | 6.13e-08 | 230 | 166 | 13 | int:MAPRE3 |
| Interaction | TNIK interactions | SHANK1 DLGAP1 CACNB4 ANK3 FOXP2 CLASP1 MINK1 LMNB2 ARHGAP39 HUWE1 UBN2 CEP170 KIAA1217 DLG1 CTNND2 MGA | 1.11e-07 | 381 | 166 | 16 | int:TNIK |
| Interaction | FMR1 interactions | DLGAP1 CACNB2 CACNB4 ARHGAP24 TCF20 CLASP1 BAG3 PUM2 CHD7 CEP170 NCOR1 WTIP AHNAK KIAA1217 DLG1 PUM1 AFF4 SMG6 | 4.82e-07 | 536 | 166 | 18 | int:FMR1 |
| Interaction | LATS1 interactions | SLAIN2 KRT6A PDE1C WWC3 SIPA1L3 MINK1 DVL1 WWC2 WTIP KIAA1217 EIF4B MYOM2 TAB1 PLEC PUM1 MGA | 7.67e-07 | 440 | 166 | 16 | int:LATS1 |
| Interaction | PRPH interactions | KRT2 KRT6A KRT8 KRT14 SIPA1L3 BAG3 KRT76 KIAA1217 CEP41 PLEC ZMYM6 | 1.05e-06 | 204 | 166 | 11 | int:PRPH |
| Interaction | KCTD13 interactions | SHANK1 KRT2 EPS8 DLGAP1 KRT6A CACNB2 PDE1C CACNB4 KRT14 ANK3 CLASP1 MARK1 SIPA1L3 MINK1 ARHGAP39 SPECC1 CEP170 PTPRA MAP1S SBF1 NRXN2 KIAA1217 EIF4B OSBPL10 KMT2A DLG1 PLEC CTNND2 UTRN LRRFIP2 | 1.10e-06 | 1394 | 166 | 30 | int:KCTD13 |
| Interaction | C11orf52 interactions | EPS8 CDC42BPA ANK3 MARK1 SIPA1L3 MINK1 SPECC1 TULP3 NDRG1 SBF1 DLG1 ROBO1 UTRN | 1.91e-06 | 311 | 166 | 13 | int:C11orf52 |
| Interaction | EPB41L4A interactions | 2.45e-06 | 140 | 166 | 9 | int:EPB41L4A | |
| Interaction | SIAH1 interactions | BAG3 PUM2 TFDP1 MAP3K5 PARD6B SNCAIP ATXN7 KIAA1217 RLIM PUM1 AFF4 | 2.50e-06 | 223 | 166 | 11 | int:SIAH1 |
| Interaction | KRT84 interactions | 2.98e-06 | 49 | 166 | 6 | int:KRT84 | |
| Interaction | YAP1 interactions | PCNP KRT6A KRT14 TCF20 ANK3 WWC3 SIPA1L3 BAG3 HUWE1 HRNR FLG2 UBN2 CEP170 NCOR1 WWC2 KRT76 NDRG1 GTF3C1 AHNAK EIF4B KMT2A DLG1 TAB1 PLEC MGA | 3.53e-06 | 1095 | 166 | 25 | int:YAP1 |
| Interaction | DCTN1 interactions | SLAIN2 KRT2 KRT6A KRT8 CLASP1 TBC1D5 BAG3 DVL1 CTIF HUWE1 SPECC1 CEP170 KRT76 MAP1S KIAA1217 CEP41 | 3.71e-06 | 497 | 166 | 16 | int:DCTN1 |
| Interaction | PHLPP1 interactions | PCNP RBM15 KRT8 KIF26B DVL1 DVL3 CEP170 AHNAK KIAA1217 EIF4B DLG1 ROBO1 PLEC | 4.05e-06 | 333 | 166 | 13 | int:PHLPP1 |
| Interaction | KRT28 interactions | 4.31e-06 | 30 | 166 | 5 | int:KRT28 | |
| Interaction | METTL3 interactions | KRT2 KRT6A RBM15 KRT14 ZC3H13 BAG3 LMNB2 HUWE1 HRNR FLG2 EIF4B DDX3Y | 4.80e-06 | 287 | 166 | 12 | int:METTL3 |
| Interaction | MECP2 interactions | FLG KRT2 KRT6A RBM15 KRT8 KRT14 CDC42BPA TCF20 CLASP1 MARK1 ZC3H13 CHD7 LMNB2 ARHGAP39 HRNR FLG2 CEP170 NCOR1 GTF3C1 SBF1 NRXN2 TUBGCP3 SEC61B DDX3Y PLEC SF3A2 AFF4 | 6.60e-06 | 1287 | 166 | 27 | int:MECP2 |
| Interaction | TXNIP interactions | 1.07e-05 | 212 | 166 | 10 | int:TXNIP | |
| Interaction | DLEC1 interactions | 1.08e-05 | 6 | 166 | 3 | int:DLEC1 | |
| Interaction | RHOF interactions | CDC42BPA ANK3 KIF26B MARK1 TBC1D5 SIPA1L3 MINK1 RALGAPB LMNB2 ARHGAP39 SPECC1 PARD6B CCM2 NDRG1 SBF1 DLG1 UTRN TNS3 | 1.17e-05 | 673 | 166 | 18 | int:RHOF |
| Interaction | METTL14 interactions | FLG KRT2 KRT8 KRT14 ZC3H13 PUM2 HUWE1 HRNR FLG2 PDCD4 EVI5 AHNAK EIF4B DDX3Y PLEC SMG6 | 1.58e-05 | 558 | 166 | 16 | int:METTL14 |
| Interaction | OCLN interactions | CDC42BPA ANK3 KIF26B SIPA1L3 MINK1 DVL1 ARHGAP39 EPB41L4A SPECC1 TULP3 NDRG1 SEC61B DLG1 ROBO1 UTRN | 1.74e-05 | 500 | 166 | 15 | int:OCLN |
| Interaction | PHTF1 interactions | 1.94e-05 | 20 | 166 | 4 | int:PHTF1 | |
| Interaction | RAC1 interactions | EPS8 DLGAP1 RBM15 CDC42BPA ANK3 KIF26B TBC1D5 SIPA1L3 MINK1 RALGAPB DVL1 LMNB2 ARHGAP39 HUWE1 SPECC1 PARD6B CCM2 SBF1 OSBPL10 DLG1 ROBO1 UTRN TNS3 | 2.13e-05 | 1063 | 166 | 23 | int:RAC1 |
| Interaction | SRPK2 interactions | USP36 SLAIN2 RBM15 ANK3 CLASP1 ZC3H13 SIPA1L3 BAG3 TOGARAM1 EPB41L4A CEP170 CCM2 MAP1S EIF4B SERPING1 AKAP13 TNS3 FAM43A | 2.71e-05 | 717 | 166 | 18 | int:SRPK2 |
| Interaction | HDAC2 interactions | USP36 SLAIN2 KRT2 KRT6A KRT14 TCF20 CDKN2AIP BAG3 HUWE1 HRNR FOXA3 TFDP1 NCOR1 AHNAK TUBGCP3 RLIM CDADC1 KMT2A TAB1 RAI1 | 3.06e-05 | 865 | 166 | 20 | int:HDAC2 |
| Interaction | DRC3 interactions | 3.48e-05 | 23 | 166 | 4 | int:DRC3 | |
| Interaction | GRB2 interactions | SLAIN2 KRT2 EPS8 DLGAP1 KRT6A KRT8 KRT14 MINK1 BAG3 HUWE1 TULP3 CEP170 PTPRA AHNAK TAB1 PLEC SH2D1A SF3A2 ZMYM6 | 3.78e-05 | 806 | 166 | 19 | int:GRB2 |
| Interaction | KRT12 interactions | 4.15e-05 | 24 | 166 | 4 | int:KRT12 | |
| Interaction | FBXO22 interactions | RBM15 ANK3 CLASP1 CDKN2AIP CCDC57 NCOR1 GTF3C1 MAP1S EIF4B NAV2 KMT2A MYOM2 PUM1 WNK4 RAI1 | 4.22e-05 | 540 | 166 | 15 | int:FBXO22 |
| Interaction | ASF1A interactions | 4.26e-05 | 249 | 166 | 10 | int:ASF1A | |
| Interaction | RFPL4B interactions | 4.59e-05 | 48 | 166 | 5 | int:RFPL4B | |
| Interaction | DIRAS2 interactions | 6.79e-05 | 52 | 166 | 5 | int:DIRAS2 | |
| Interaction | KRT76 interactions | 6.82e-05 | 84 | 166 | 6 | int:KRT76 | |
| Interaction | RHOD interactions | CDC42BPA ANK3 KIF26B TBC1D5 MINK1 RALGAPB LMNB2 ARHGAP39 SPECC1 CCM2 SBF1 DLG1 UTRN TNS3 LRRFIP2 | 8.07e-05 | 572 | 166 | 15 | int:RHOD |
| Interaction | CLK1 interactions | 8.69e-05 | 219 | 166 | 9 | int:CLK1 | |
| Interaction | EGR2 interactions | 8.82e-05 | 171 | 166 | 8 | int:EGR2 | |
| Interaction | MAPRE1 interactions | SLAIN2 KRT8 CLASP1 BAG3 MARCHF7 LMNB2 SPECC1 CEP170 TTBK1 MAP1S KIAA1217 EIF4B NAV2 PLEC | 9.44e-05 | 514 | 166 | 14 | int:MAPRE1 |
| Interaction | EPHA2 interactions | EPS8 CACNB2 SASH1 ANK3 MARK1 MINK1 RALGAPB EPB41L4A SPECC1 PARD6B CELSR2 SBF1 KIAA1217 OSBPL10 DLG1 ROBO1 UTRN | 9.54e-05 | 719 | 166 | 17 | int:EPHA2 |
| Interaction | ZUP1 interactions | 9.95e-05 | 174 | 166 | 8 | int:ZUP1 | |
| Interaction | CYLD interactions | SLAIN2 FLG KRT2 DLGAP1 KRT6A KRT8 KRT14 DVL1 DVL3 MUC19 HUWE1 HRNR FLG2 CEP170 AHNAK EIF4B TAB1 PLEC MGA | 1.01e-04 | 868 | 166 | 19 | int:CYLD |
| Interaction | C6orf141 interactions | 1.13e-04 | 92 | 166 | 6 | int:C6orf141 | |
| Interaction | KLHL40 interactions | 1.25e-04 | 59 | 166 | 5 | int:KLHL40 | |
| Interaction | DLGAP1 interactions | 1.26e-04 | 180 | 166 | 8 | int:DLGAP1 | |
| Interaction | PRICKLE1 interactions | 1.35e-04 | 60 | 166 | 5 | int:PRICKLE1 | |
| Interaction | FBXW11 interactions | BAG3 MTSS1 PER1 HUWE1 PDCD4 MAP3K5 MAP1S SBF1 GLI2 EIF4B TUBGCP3 AKAP13 PUM1 | 1.54e-04 | 473 | 166 | 13 | int:FBXW11 |
| Interaction | THRB interactions | 1.58e-04 | 186 | 166 | 8 | int:THRB | |
| Interaction | PRICKLE2 interactions | 1.58e-04 | 62 | 166 | 5 | int:PRICKLE2 | |
| Interaction | PINK1 interactions | USP36 FLG RBM15 ZC3H13 SARM1 BAG3 LMNB2 HUWE1 FLG2 SPECC1 SNCAIP NDRG1 AHNAK EIF4B SEC61B PLEC | 1.60e-04 | 679 | 166 | 16 | int:PINK1 |
| Interaction | INVS interactions | 1.70e-04 | 99 | 166 | 6 | int:INVS | |
| Interaction | SLIT2 interactions | 1.71e-04 | 63 | 166 | 5 | int:SLIT2 | |
| Interaction | KRT20 interactions | 1.71e-04 | 63 | 166 | 5 | int:KRT20 | |
| Interaction | KCNE3 interactions | MINK1 DVL3 MARCHF7 ARHGAP39 OSBP PTPRA SBF1 OSBPL10 ROBO1 TAB1 | 1.78e-04 | 296 | 166 | 10 | int:KCNE3 |
| Interaction | EIF3F interactions | 1.78e-04 | 296 | 166 | 10 | int:EIF3F | |
| Interaction | KRT26 interactions | 1.90e-04 | 35 | 166 | 4 | int:KRT26 | |
| Interaction | KRT25 interactions | 1.90e-04 | 35 | 166 | 4 | int:KRT25 | |
| Interaction | KRT14 interactions | 1.96e-04 | 192 | 166 | 8 | int:KRT14 | |
| Interaction | EZR interactions | SLAIN2 KRT8 ARHGAP24 CDC42BPA ANK3 MINK1 BAG3 DVL3 NDRG1 AHNAK RLIM DLG1 TAB1 UTRN | 2.02e-04 | 553 | 166 | 14 | int:EZR |
| Interaction | WWTR1 interactions | SLAIN2 TCF20 ANK3 BAG3 DVL1 DVL3 CEP170 NCOR1 GTF3C1 PKD2 KMT2A DLG1 | 2.03e-04 | 422 | 166 | 12 | int:WWTR1 |
| Interaction | USP9X interactions | DLGAP1 KRT8 ANK3 MINK1 BAG3 MARCHF7 HUWE1 MAP3K5 CEP170 EIF4B SEC61B GNL1 | 2.03e-04 | 422 | 166 | 12 | int:USP9X |
| Interaction | WTAP interactions | 2.11e-04 | 194 | 166 | 8 | int:WTAP | |
| Interaction | ARL4D interactions | 2.11e-04 | 146 | 166 | 7 | int:ARL4D | |
| Interaction | RHOJ interactions | RBM15 CDC42BPA TBC1D5 MINK1 RALGAPB DVL3 LMNB2 SPECC1 TULP3 PARD6B NDRG1 SBF1 DLG1 ROBO1 UTRN | 2.44e-04 | 633 | 166 | 15 | int:RHOJ |
| Interaction | DVL1 interactions | 2.59e-04 | 151 | 166 | 7 | int:DVL1 | |
| Interaction | CSNK1E interactions | 2.64e-04 | 311 | 166 | 10 | int:CSNK1E | |
| Interaction | LRCH3 interactions | 2.73e-04 | 108 | 166 | 6 | int:LRCH3 | |
| Interaction | AP2B1 interactions | USP36 SLAIN2 ARHGAP24 TBC1D5 SIPA1L3 RALGAPB CTIF MTMR4 RLIM OSBPL10 AFF4 | 2.75e-04 | 373 | 166 | 11 | int:AP2B1 |
| Interaction | FEV interactions | 2.86e-04 | 203 | 166 | 8 | int:FEV | |
| Interaction | SULT1C4 interactions | 3.01e-04 | 110 | 166 | 6 | int:SULT1C4 | |
| Interaction | LYN interactions | CDC42BPA ANK3 KIF26B MINK1 ARHGAP39 SPECC1 TULP3 NDRG1 KIAA1217 RLIM KMT2A DLG1 ROBO1 SH2D1A UTRN SF3A2 | 3.10e-04 | 720 | 166 | 16 | int:LYN |
| Interaction | HSF2BP interactions | WASHC1 MARCHF7 TULP3 MAP3K5 PARD6B MTMR4 PKD2 ROBO3 CEP57 INPP5J | 3.16e-04 | 318 | 166 | 10 | int:HSF2BP |
| Interaction | FGD5 interactions | 3.26e-04 | 207 | 166 | 8 | int:FGD5 | |
| Interaction | CSNK2A1 interactions | FLG ZC3H13 MINK1 DVL1 DVL3 PDCD4 CEP170 NCOR1 OSBP SNCAIP ASXL3 EIF4B SEC61B KMT2A MGA CEP57 GNL1 ANKS3 RNF111 | 3.45e-04 | 956 | 166 | 19 | int:CSNK2A1 |
| Interaction | MKRN2 interactions | FOXP2 SARM1 PUM2 CHD7 TULP3 PTPRA CELSR2 GLI2 DLG1 ROBO1 PUM1 | 3.60e-04 | 385 | 166 | 11 | int:MKRN2 |
| Interaction | RNF208 interactions | 3.87e-04 | 75 | 166 | 5 | int:RNF208 | |
| Interaction | KRT13 interactions | 4.01e-04 | 116 | 166 | 6 | int:KRT13 | |
| Interaction | PPP1CC interactions | USP36 DLGAP1 RBM15 MARK1 ZC3H13 BTBD10 SPECC1 NCOR1 SNCAIP KIAA1217 RLIM DLG1 AKAP13 PLEC LRRFIP2 SMG6 | 4.06e-04 | 738 | 166 | 16 | int:PPP1CC |
| Interaction | TOP3B interactions | RBM15 CDC42BPA PPRC1 SIPA1L3 DVL1 PER1 RAP1GAP2 CTIF LMNB2 HUWE1 MAP3K5 NCOR1 HEG1 CELSR2 MAP1S SBF1 AHNAK NAV2 AKAP13 ZFYVE26 PLEC PUM1 RAI1 SMG6 BAHCC1 | 4.25e-04 | 1470 | 166 | 25 | int:TOP3B |
| Interaction | PHKA1 interactions | 4.27e-04 | 43 | 166 | 4 | int:PHKA1 | |
| Interaction | RNF41 interactions | 4.27e-04 | 164 | 166 | 7 | int:RNF41 | |
| Interaction | TAOK2 interactions | 4.27e-04 | 164 | 166 | 7 | int:TAOK2 | |
| Interaction | SIRT7 interactions | ZSWIM8 RBM15 TCF20 ZC3H13 CHD7 LMNB2 HUWE1 CEP170 GTF3C1 SBF1 AHNAK KMT2A PLEC PUM1 UTRN RAI1 | 4.44e-04 | 744 | 166 | 16 | int:SIRT7 |
| Interaction | AFDN interactions | CDC42BPA SIPA1L3 MINK1 ARHGAP39 SPECC1 NRXN2 KIAA1217 KMT2A DLG1 UTRN | 4.53e-04 | 333 | 166 | 10 | int:AFDN |
| Interaction | ARL14 interactions | 4.60e-04 | 119 | 166 | 6 | int:ARL14 | |
| Interaction | MARK2 interactions | 4.60e-04 | 274 | 166 | 9 | int:MARK2 | |
| Interaction | PAN2 interactions | KRT2 KRT6A KRT8 LMNB2 SPECC1 CEP170 EIF4B PLEC SF3A2 QSOX2 LRRFIP2 | 4.66e-04 | 397 | 166 | 11 | int:PAN2 |
| Interaction | OBSL1 interactions | KRT6A RBM15 KRT8 KRT14 TCF20 DVL3 LMNB2 HUWE1 TULP3 MTMR4 GTF3C1 SLC7A6OS AHNAK PLEC PIPSL MGA UTRN SF3A2 | 4.74e-04 | 902 | 166 | 18 | int:OBSL1 |
| Interaction | PSME3 interactions | BAG3 DVL3 HUWE1 TULP3 ASXL3 AHNAK TUBGCP3 PLEC MGA INPP5J RNF111 | 4.76e-04 | 398 | 166 | 11 | int:PSME3 |
| Interaction | CASK interactions | 5.04e-04 | 221 | 166 | 8 | int:CASK | |
| Interaction | KRT7 interactions | 5.21e-04 | 80 | 166 | 5 | int:KRT7 | |
| Interaction | ARHGAP21 interactions | 5.35e-04 | 223 | 166 | 8 | int:ARHGAP21 | |
| Interaction | ACTN2 interactions | 5.48e-04 | 171 | 166 | 7 | int:ACTN2 | |
| Interaction | ATG16L1 interactions | PCNP ANK3 WWC3 CDKN2AIP ZC3H13 SIPA1L3 KIAA0586 DVL1 SPECC1 CEP170 GLI2 KIAA1217 EIF4B TUBGCP3 OSBPL10 SEC61B ROBO1 AKAP13 PLEC TNS3 LRRFIP2 | 5.81e-04 | 1161 | 166 | 21 | int:ATG16L1 |
| Interaction | RHOB interactions | EPS8 CDC42BPA ANK3 KIF26B SIPA1L3 MINK1 RALGAPB ARHGAP39 SPECC1 TULP3 CCM2 NDRG1 SBF1 DLG1 ROBO1 AKAP13 UTRN | 5.85e-04 | 840 | 166 | 17 | int:RHOB |
| Cytoband | 12q13.13 | 1.16e-04 | 67 | 170 | 4 | 12q13.13 | |
| Cytoband | 4q35.1 | 3.26e-04 | 36 | 170 | 3 | 4q35.1 | |
| GeneFamily | CD molecules|Mucins | 4.53e-06 | 21 | 98 | 4 | 648 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 5.32e-06 | 7 | 98 | 3 | 1350 | |
| GeneFamily | Keratins, type II | 1.29e-05 | 27 | 98 | 4 | 609 | |
| GeneFamily | PDZ domain containing | 1.89e-05 | 152 | 98 | 7 | 1220 | |
| GeneFamily | Dishevelled segment polarity proteins|PDZ domain containing | 1.73e-04 | 4 | 98 | 2 | 505 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 3.67e-04 | 26 | 98 | 3 | 904 | |
| GeneFamily | Sterile alpha motif domain containing | 1.34e-03 | 88 | 98 | 4 | 760 | |
| GeneFamily | Ring finger proteins|Membrane associated ring-CH-type fingers | 1.55e-03 | 11 | 98 | 2 | 60 | |
| GeneFamily | Fibronectin type III domain containing | 1.79e-03 | 160 | 98 | 5 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.84e-03 | 161 | 98 | 5 | 593 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 1.85e-03 | 12 | 98 | 2 | 670 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 2.92e-03 | 15 | 98 | 2 | 903 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 3.32e-03 | 16 | 98 | 2 | 14 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.28e-03 | 206 | 98 | 5 | 682 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 5.71e-03 | 21 | 98 | 2 | 813 | |
| GeneFamily | Calcium voltage-gated channel subunits | 8.68e-03 | 26 | 98 | 2 | 253 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | EPS8 CDC42BPA MTSS1 MAP3K5 PIEZO2 FBXL7 AHNAK ROBO1 UTRN TNS3 | 2.42e-07 | 177 | 169 | 10 | M39245 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CACNB4 KRT14 ARHGAP24 ARPP21 ANK3 ADAMTS3 MARK1 CCDC186 SRRM4 RIMS3 MTSS1 MUC19 RAP1GAP2 XKR4 UBN2 PTPRT PIEZO2 NRXN2 ASXL3 ROBO1 LSM11 CTNND2 RAI1 | 7.56e-07 | 1106 | 169 | 23 | M39071 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 2.25e-06 | 176 | 169 | 9 | M39223 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | FLG CLASP1 PPRC1 PUM2 TOGARAM1 MAP3K5 CEP170 HEG1 TUBGCP3 MORC3 PUM1 | 4.28e-06 | 300 | 169 | 11 | M8702 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | USP36 PCNP CCDC186 PER1 CHD7 PDCD4 OSBP ATXN7 RLIM GNL1 QSOX2 AFF4 SORL1 | 4.97e-06 | 432 | 169 | 13 | M41149 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | EPS8 SASH1 ANK3 FOXP2 MARK1 KIAA0586 FAM174B LDLRAD3 SPECC1 PDCD4 SEMA4G MAP3K5 SLC45A4 NCOR1 MTMR4 TTBK1 NDRG1 NAV2 LSM11 PLEC SORL1 | 9.15e-06 | 1102 | 169 | 21 | M2369 |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | CDC42BPA TCF20 DVL1 HUWE1 DLG1 TAB1 MORC3 SF3A2 AFF4 LRRFIP2 | 1.05e-05 | 269 | 169 | 10 | M41203 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | EPS8 CDC42BPA CLASP1 PUM2 MARCHF7 CEP170 EVI5 HEG1 PTPRA FBXL7 TUBGCP3 PKD2 PUM1 | 1.12e-05 | 466 | 169 | 13 | M13522 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPS8 CDC42BPA SASH1 CLASP1 PUM2 MARCHF7 TOGARAM1 CTIF CEP170 EVI5 HEG1 PTPRA FBXL7 TUBGCP3 PKD2 DLG1 AKAP13 PUM1 | 1.14e-05 | 856 | 169 | 18 | M4500 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | SLAIN2 CDC42BPA MARK1 BAG3 MTSS1 RAP1GAP2 FAM174B TOGARAM1 CHD7 HUWE1 NDRG1 GTF3C1 EIF4B NAV2 ROBO1 DDX3Y UTRN AFF4 SORL1 | 1.22e-05 | 946 | 169 | 19 | M39169 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | EPS8 SASH1 ANK3 FOXP2 MARK1 KIAA0586 FAM174B LDLRAD3 SPECC1 PDCD4 SEMA4G MAP3K5 SLC45A4 NCOR1 MTMR4 TTBK1 NDRG1 NAV2 LSM11 PLEC SORL1 | 1.23e-05 | 1124 | 169 | 21 | MM1070 |
| Coexpression | GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP | 4.23e-05 | 196 | 169 | 8 | M8135 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 4.71e-05 | 199 | 169 | 8 | M5893 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_LUNG_DN | 4.71e-05 | 199 | 169 | 8 | M4350 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN | 4.88e-05 | 200 | 169 | 8 | M9472 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_UP | 4.88e-05 | 200 | 169 | 8 | M5973 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | ARPP21 ANK3 MARK1 SRRM4 MUC19 RAP1GAP2 XKR4 UBN2 PTPRT NRXN2 ASXL3 ROBO1 | 5.21e-05 | 465 | 169 | 12 | M39066 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | KRT8 TCF20 ZC3H13 MARCHF7 TFDP1 NCOR1 AHNAK EIF4B PUM1 RNF111 SMG6 BAHCC1 | 5.42e-05 | 467 | 169 | 12 | M1347 |
| Coexpression | KIM_GERMINAL_CENTER_T_HELPER_DN | 5.55e-05 | 12 | 169 | 3 | M1408 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML1 | CACNB4 ARPP21 ANK3 FOXP2 SRRM4 PER1 RAP1GAP2 XKR4 ASXL3 ROBO1 | 5.67e-05 | 328 | 169 | 10 | M39064 |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 6.83e-05 | 155 | 169 | 7 | M39246 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | EPS8 KRT6A SASH1 ANK3 BAG3 PER1 FOXA3 NDRG1 PKD2 KMT2A ROBO1 ZMYM6 AFF4 RAI1 SORL1 | 7.13e-05 | 721 | 169 | 15 | M1999 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | KRT8 TCF20 ZC3H13 MARCHF7 TFDP1 NCOR1 AHNAK EIF4B PUM1 RNF111 SMG6 BAHCC1 | 7.62e-05 | 484 | 169 | 12 | MM999 |
| Coexpression | LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED | 1.04e-04 | 38 | 169 | 4 | M39244 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 1.17e-04 | 169 | 169 | 7 | M39230 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 1.33e-04 | 295 | 169 | 9 | M39121 | |
| Coexpression | GSE27896_HDAC6_KO_VS_WT_TREG_UP | 1.51e-04 | 176 | 169 | 7 | M8248 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | EPS8 KRT8 SASH1 ANK3 ADAMTS3 CCDC186 DVL3 CTIF SPECC1 PARD6B WWC2 HEG1 SNCAIP NDRG1 NRXN2 NAV2 PLEC | 1.56e-04 | 955 | 169 | 17 | M45680 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | ARPP21 ANK3 MARK1 SRRM4 RIMS3 MTSS1 MUC19 RAP1GAP2 XKR4 UBN2 PTPRT NRXN2 ASXL3 ROBO1 | 1.96e-04 | 703 | 169 | 14 | M39070 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 2.15e-04 | 84 | 169 | 5 | M13008 | |
| Coexpression | GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP | 2.19e-04 | 187 | 169 | 7 | M7572 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 2.27e-04 | 85 | 169 | 5 | M10575 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | PDE1C ARPP21 ANK3 SRRM4 ARHGAP39 XKR4 UBN2 CELSR2 NRXN2 KMT2A | 2.28e-04 | 389 | 169 | 10 | M39102 |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 2.40e-04 | 86 | 169 | 5 | M39247 | |
| Coexpression | ONDER_CDH1_TARGETS_2_DN | KRT6A KRT8 KRT14 ANK3 MARK1 RIMS3 MTSS1 NDRG1 CELSR2 ROBO1 SORL1 | 2.64e-04 | 473 | 169 | 11 | M4306 |
| Coexpression | BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN | 2.67e-04 | 88 | 169 | 5 | M2232 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 2.69e-04 | 137 | 169 | 6 | M39241 | |
| Coexpression | GSE29618_BCELL_VS_MDC_UP | 2.74e-04 | 194 | 169 | 7 | M4943 | |
| Coexpression | GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_DN | 2.74e-04 | 194 | 169 | 7 | M6908 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | USP36 TCF20 CDKN2AIP BAG3 RALGAPB PER1 MARCHF7 PDCD4 OSBP NDRG1 MAP1S NAV2 MORC3 PUM1 AFF4 | 2.96e-04 | 822 | 169 | 15 | M6782 |
| Coexpression | GSE28408_LY6G_POS_VS_NEG_DC_UP | 3.01e-04 | 197 | 169 | 7 | M9547 | |
| Coexpression | GSE24142_DN2_VS_DN3_THYMOCYTE_DN | 3.20e-04 | 199 | 169 | 7 | M4558 | |
| Coexpression | GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN | 3.20e-04 | 199 | 169 | 7 | M7965 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP | 3.30e-04 | 200 | 169 | 7 | M9449 | |
| Coexpression | GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_UP | 3.30e-04 | 200 | 169 | 7 | M9860 | |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_UP | 3.30e-04 | 200 | 169 | 7 | M6254 | |
| Coexpression | GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN | 3.30e-04 | 200 | 169 | 7 | M5600 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | FILIP1 KRT6A KRT8 ANK3 FOXP2 ADAMTS3 KIF26B MARK1 SIPA1L3 GATA5 HUWE1 SEMA4G SNCAIP GLI2 ROBO1 AKAP13 MYOM2 CTNND2 SORL1 | 1.20e-05 | 806 | 161 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | DLGAP1 TCF20 KIF26B TBC1D5 SIPA1L3 DLG1 ROBO1 CTNND2 PUM1 UTRN SMG6 | 1.56e-10 | 186 | 170 | 11 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | DLGAP1 TCF20 KIF26B TBC1D5 SIPA1L3 DLG1 ROBO1 CTNND2 PUM1 UTRN SMG6 | 1.56e-10 | 186 | 170 | 11 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | FILIP1 EPS8 CACNB2 MARK1 LDLRAD3 SPECC1 PIEZO2 GLI2 ROBO1 UTRN | 2.60e-09 | 185 | 170 | 10 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | FILIP1 EPS8 CACNB2 MARK1 LDLRAD3 SPECC1 PIEZO2 GLI2 ROBO1 UTRN | 2.60e-09 | 185 | 170 | 10 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | SLAIN2 EPS8 CDC42BPA CCDC186 ZC3H13 SPECC1 NCOR1 RLIM UTRN LRRFIP2 | 5.25e-09 | 199 | 170 | 10 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | SHANK1 ADAMTS3 SIPA1L3 RAP1GAP2 XKR4 SEMA4G LSM11 MARCHF11 INPP5J | 1.70e-08 | 167 | 170 | 9 | 9efb9511a211d0824bb97f82c1a5860c43d2138f |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | SHANK1 ADAMTS3 SIPA1L3 RAP1GAP2 XKR4 SEMA4G LSM11 MARCHF11 INPP5J | 1.70e-08 | 167 | 170 | 9 | 904c613aac3f9919a432b110bb1dcc832b5aec0a |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-08 | 171 | 170 | 9 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | TCF20 ANK3 SIPA1L3 LDLRAD3 MAP3K5 FBXL7 KIAA1217 NAV2 OSBPL10 | 4.74e-08 | 188 | 170 | 9 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 5.43e-08 | 191 | 170 | 9 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DLGAP1 CACNB2 ADAMTS3 KIF26B LDLRAD3 PIEZO2 GLI2 ASXL3 ROBO1 | 6.20e-08 | 194 | 170 | 9 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.50e-07 | 173 | 170 | 8 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | facs|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-07 | 175 | 170 | 8 | 53e96956019f984decc1c81376ebc88fbf3c4d40 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.17e-07 | 177 | 170 | 8 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.54e-07 | 179 | 170 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.54e-07 | 179 | 170 | 8 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-07 | 185 | 170 | 8 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.32e-07 | 187 | 170 | 8 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.32e-07 | 187 | 170 | 8 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.58e-07 | 188 | 170 | 8 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.58e-07 | 188 | 170 | 8 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.13e-07 | 190 | 170 | 8 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 7.13e-07 | 190 | 170 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.42e-07 | 191 | 170 | 8 | de54dab85db70f847de75b3b6d7667a0e13b9bfb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.42e-07 | 191 | 170 | 8 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.42e-07 | 191 | 170 | 8 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.71e-07 | 192 | 170 | 8 | 24e2f15f5767a97eb3b389922bcfd7b13805e1ce | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.02e-07 | 193 | 170 | 8 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.34e-07 | 194 | 170 | 8 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.34e-07 | 194 | 170 | 8 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.67e-07 | 195 | 170 | 8 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.67e-07 | 195 | 170 | 8 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.67e-07 | 195 | 170 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 9.01e-07 | 196 | 170 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.01e-07 | 196 | 170 | 8 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | NS-critical-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.01e-07 | 196 | 170 | 8 | 97e16d9833e4083d719ca7058d5fc9b11edb37e3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.36e-07 | 197 | 170 | 8 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.36e-07 | 197 | 170 | 8 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.72e-07 | 198 | 170 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 9.72e-07 | 198 | 170 | 8 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 9.72e-07 | 198 | 170 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-06 | 199 | 170 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.01e-06 | 199 | 170 | 8 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.05e-06 | 200 | 170 | 8 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-06 | 200 | 170 | 8 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.05e-06 | 200 | 170 | 8 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-06 | 200 | 170 | 8 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.05e-06 | 200 | 170 | 8 | 347a510755374c6a66acee326565dfc447993f18 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.05e-06 | 200 | 170 | 8 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | facs|World / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.33e-06 | 171 | 170 | 7 | bb71e816dde44fda6af0ad98d979be9f8740fda6 | |
| ToppCell | facs|World / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-06 | 171 | 170 | 7 | 5bcb96ed7fc15548f2dc9cf47482f890640cb39c | |
| ToppCell | COVID-19-kidney-REN+Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.85e-06 | 174 | 170 | 7 | 8393f0b43c767839c1630bcb952d62b42efc788d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.43e-06 | 177 | 170 | 7 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.43e-06 | 177 | 170 | 7 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.43e-06 | 177 | 170 | 7 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.43e-06 | 177 | 170 | 7 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | facs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-06 | 179 | 170 | 7 | 8001db3044e8657980e24422377c4fdb0d7b323e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.84e-06 | 179 | 170 | 7 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-06 | 184 | 170 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-06 | 184 | 170 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-06 | 184 | 170 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 7.00e-06 | 184 | 170 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.51e-06 | 186 | 170 | 7 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.51e-06 | 186 | 170 | 7 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.78e-06 | 187 | 170 | 7 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.78e-06 | 187 | 170 | 7 | 48bfdb3504c3fefe5db3abac4b790c369680ab4e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.78e-06 | 187 | 170 | 7 | 958402fcc78f4c7a7d13d659d776f3817137975f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 8.33e-06 | 189 | 170 | 7 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.33e-06 | 189 | 170 | 7 | 06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.33e-06 | 189 | 170 | 7 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.63e-06 | 190 | 170 | 7 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 8.63e-06 | 190 | 170 | 7 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.63e-06 | 190 | 170 | 7 | c247562df3e1aa3173c9f01a74d5831f0764a1b2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.63e-06 | 190 | 170 | 7 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 8.63e-06 | 190 | 170 | 7 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.63e-06 | 190 | 170 | 7 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.63e-06 | 190 | 170 | 7 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.63e-06 | 190 | 170 | 7 | 5cea8298c8336c136ba009630c9e48d4bc832cb2 | |
| ToppCell | BL-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.93e-06 | 191 | 170 | 7 | 3f9b8c4fb72ae6f3167b187e6715c4dcb3159f98 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.93e-06 | 191 | 170 | 7 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.93e-06 | 191 | 170 | 7 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 8.93e-06 | 191 | 170 | 7 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.93e-06 | 191 | 170 | 7 | 297bc79adc5fef211497819b4861b52cd26ac754 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 8.93e-06 | 191 | 170 | 7 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.93e-06 | 191 | 170 | 7 | e1ec165ba6578cefd88895e7e183190e79f733a4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.93e-06 | 191 | 170 | 7 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.93e-06 | 191 | 170 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.23e-06 | 192 | 170 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.23e-06 | 192 | 170 | 7 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 9.23e-06 | 192 | 170 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.23e-06 | 192 | 170 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.55e-06 | 193 | 170 | 7 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.55e-06 | 193 | 170 | 7 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.55e-06 | 193 | 170 | 7 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.55e-06 | 193 | 170 | 7 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.55e-06 | 193 | 170 | 7 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.88e-06 | 194 | 170 | 7 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.88e-06 | 194 | 170 | 7 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.88e-06 | 194 | 170 | 7 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.88e-06 | 194 | 170 | 7 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| Computational | Genes in the cancer module 68. | 1.01e-04 | 26 | 103 | 4 | MODULE_68 | |
| Computational | Keratin. | 1.01e-04 | 26 | 103 | 4 | MODULE_298 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 4.75e-06 | 171 | 166 | 9 | 7535_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 8.61e-06 | 184 | 166 | 9 | 2321_DN | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 1.02e-05 | 188 | 166 | 9 | 1023_UP | |
| Drug | Forskolin, from Coleus forskohlii; Down 200; 0.5uM; PC3; HT_HG-U133A | USP36 CDC42BPA ANK3 ADAMTS3 PPRC1 SARM1 RAP1GAP2 WWC2 CDADC1 | 1.26e-05 | 193 | 166 | 9 | 7059_DN |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 1.43e-05 | 196 | 166 | 9 | 5063_DN | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; HL60; HT_HG-U133A | 1.49e-05 | 197 | 166 | 9 | 2558_DN | |
| Drug | Ebselen [60940-34-3]; Up 200; 14.6uM; PC3; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 5778_UP | |
| Drug | Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 3583_UP | |
| Drug | Fursultiamine Hydrochloride [2105-43-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 7349_DN | |
| Drug | Ginkgolide A [15291-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 3260_UP | |
| Drug | Solanine alpha [20562-02-1]; Down 200; 4.6uM; PC3; HT_HG-U133A | PDE1C ARHGAP24 CCDC186 CDKN2AIP SARM1 PER1 PDCD4 CDADC1 TAB1 | 1.61e-05 | 199 | 166 | 9 | 4087_DN |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 1.61e-05 | 199 | 166 | 9 | 2319_DN | |
| Drug | 1i9n | 3.06e-05 | 25 | 166 | 4 | CID000446239 | |
| Drug | GW8510; Down 200; 10uM; PC3; HT_HG-U133A | 5.88e-05 | 182 | 166 | 8 | 7067_DN | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A | 6.12e-05 | 183 | 166 | 8 | 1668_UP | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 6.36e-05 | 184 | 166 | 8 | 1081_UP | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 8.25e-05 | 191 | 166 | 8 | 7435_DN | |
| Drug | Simvastatin [79902-63-9]; Up 200; 9.6uM; PC3; HT_HG-U133A | 8.56e-05 | 192 | 166 | 8 | 4244_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A | 9.54e-05 | 195 | 166 | 8 | 1785_UP | |
| Drug | Thiamphenicol [15318-45-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 9.54e-05 | 195 | 166 | 8 | 7033_UP | |
| Drug | Hesperetin [520-33-2]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 9.88e-05 | 196 | 166 | 8 | 5350_UP | |
| Drug | Carbamazepine [298-46-4]; Up 200; 17uM; MCF7; HT_HG-U133A | 9.88e-05 | 196 | 166 | 8 | 5518_UP | |
| Drug | Prostaglandin E1; Down 200; 10uM; PC3; HT_HG-U133A | 9.88e-05 | 196 | 166 | 8 | 6571_DN | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; MCF7; HT_HG-U133A | 9.88e-05 | 196 | 166 | 8 | 3429_DN | |
| Drug | Stachydrine hydrochloride; Up 200; 22.2uM; HL60; HG-U133A | 1.02e-04 | 197 | 166 | 8 | 1751_UP | |
| Drug | Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 1.02e-04 | 197 | 166 | 8 | 3939_DN | |
| Drug | Meglumine [6284-40-8]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 1.02e-04 | 197 | 166 | 8 | 5285_DN | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.02e-04 | 197 | 166 | 8 | 2779_UP | |
| Drug | SC-58125; Up 200; 10uM; MCF7; HG-U133A | 1.06e-04 | 198 | 166 | 8 | 208_UP | |
| Drug | Canavanine sulfate monohydrate (L,+) [206996-57-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 4782_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; PC3; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 4464_DN | |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 2256_DN | |
| Drug | Bergenin monohydrate [477-90-7]; Up 200; 11.6uM; PC3; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 5870_UP | |
| Drug | Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 2623_DN | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 1482_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 1650_DN | |
| Drug | Nimesulide [51803-78-2]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.06e-04 | 198 | 166 | 8 | 7024_UP | |
| Drug | SR-95639A [115767-94-7]; Down 200; 10uM; PC3; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 6632_DN | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; PC3; HT_HG-U133A | 1.10e-04 | 199 | 166 | 8 | 7365_DN | |
| Drug | sodium 4-phenylbutyrate; Up 200; 1000uM; MCF7; HG-U133A | 1.10e-04 | 199 | 166 | 8 | 408_UP | |
| Disease | neuroimaging measurement | CACNB2 CDC42BPA ANK3 FOXP2 ADAMTS3 KIF26B TBC1D5 CHD7 NCOR1 CCM2 FBXL7 RLIM NAV2 ROBO1 PLEC ROBO3 CEP57 QSOX2 RAI1 SMG6 BAHCC1 | 6.15e-07 | 1069 | 165 | 21 | EFO_0004346 |
| Disease | brain measurement, neuroimaging measurement | CACNB2 ANK3 FOXP2 ADAMTS3 KIF26B CDKN2AIP TBC1D5 FBXL7 ATXN7 NAV2 ROBO1 PLEC SMG6 BAHCC1 | 2.86e-06 | 550 | 165 | 14 | EFO_0004346, EFO_0004464 |
| Disease | sensory peripheral neuropathy, remission | 7.68e-06 | 23 | 165 | 4 | EFO_0009785, MONDO_0002321 | |
| Disease | serum gamma-glutamyl transferase measurement | KRT8 ARPP21 CDC42BPA SIPA1L3 SEMA4G PARD6B WWC2 CELSR2 MAP1S AHNAK RP1L1 NAV2 KMT2A ROBO1 AKAP13 BAHCC1 | 5.81e-05 | 914 | 165 | 16 | EFO_0004532 |
| Disease | four-jointed box protein 1 measurement | 9.29e-05 | 3 | 165 | 2 | EFO_0801605 | |
| Disease | beta-amyloid 1-42 measurement | 1.31e-04 | 87 | 165 | 5 | EFO_0004670 | |
| Disease | Robinow Syndrome | 1.85e-04 | 4 | 165 | 2 | C0265205 | |
| Disease | Robinow Syndrome, Autosomal Dominant | 1.85e-04 | 4 | 165 | 2 | C4551476 | |
| Disease | lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma | 2.07e-04 | 52 | 165 | 4 | EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.21e-04 | 152 | 165 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | USP36 SLAIN2 CACNB2 ARHGAP24 NEK10 FAM174B PIEZO2 TTBK1 FBXL7 ATXN7 KIAA1217 AKAP13 DLEC1 CTNND2 ROBO3 QSOX2 TNS3 LRRFIP2 SMG6 | 3.05e-04 | 1392 | 165 | 19 | EFO_0005763 |
| Disease | response to platinum based chemotherapy, cytotoxicity measurement | 3.07e-04 | 5 | 165 | 2 | EFO_0004647, EFO_0006952 | |
| Disease | DiGeorge syndrome (is_implicated_in) | 3.07e-04 | 5 | 165 | 2 | DOID:11198 (is_implicated_in) | |
| Disease | coronary artery disease | PDE1C ADAMTS3 CDKN2AIP SRRM4 LMNB2 EPB41L4A XKR4 FOXA3 CCM2 CELSR2 MAP1S KIAA1217 AKAP13 DLEC1 TNS3 RAI1 SMG6 | 3.98e-04 | 1194 | 165 | 17 | EFO_0001645 |
| Disease | sh2 domain-containing protein 1a measurement | 4.59e-04 | 6 | 165 | 2 | EFO_0020737 | |
| Disease | renal system measurement, uric acid measurement | 4.59e-04 | 6 | 165 | 2 | EFO_0004742, EFO_0004761 | |
| Disease | mean arterial pressure | USP36 CACNB2 ARHGAP24 TCF20 CEP170 TTBK1 KIAA1217 ROBO1 SMG6 BAHCC1 | 5.30e-04 | 499 | 165 | 10 | EFO_0006340 |
| Disease | cortical surface area measurement | FILIP1 ANK3 FOXP2 ADAMTS3 KIF26B TBC1D5 ZC3H13 MARCHF7 CHD7 ARHGAP39 SLC45A4 EVI5 NCOR1 FBXL7 RP1L1 NAV2 ROBO1 SMG6 | 5.57e-04 | 1345 | 165 | 18 | EFO_0010736 |
| Disease | heart failure | 6.28e-04 | 185 | 165 | 6 | EFO_0003144 | |
| Disease | myoclonic-atonic epilepsy (implicated_via_orthology) | 6.41e-04 | 7 | 165 | 2 | DOID:0060475 (implicated_via_orthology) | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 6.41e-04 | 7 | 165 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | Autistic Disorder | 6.94e-04 | 261 | 165 | 7 | C0004352 | |
| Disease | acne | 7.03e-04 | 125 | 165 | 5 | EFO_0003894 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 7.83e-04 | 128 | 165 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 7.83e-04 | 128 | 165 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 7.83e-04 | 128 | 165 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 7.83e-04 | 128 | 165 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 7.83e-04 | 128 | 165 | 5 | C0007134 | |
| Disease | sialic acid-binding Ig-like lectin 12 measurement | 8.51e-04 | 8 | 165 | 2 | EFO_0802066 | |
| Disease | oxysterols receptor LXR-beta measurement | 1.09e-03 | 9 | 165 | 2 | EFO_0801865 | |
| Disease | glioblastoma (implicated_via_orthology) | 1.09e-03 | 9 | 165 | 2 | DOID:3068 (implicated_via_orthology) | |
| Disease | sporadic amyotrophic lateral sclerosis | 1.17e-03 | 140 | 165 | 5 | EFO_0001357 | |
| Disease | venous thromboembolism | 1.18e-03 | 460 | 165 | 9 | EFO_0004286 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.37e-03 | 145 | 165 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | neuroticism measurement, cognitive function measurement | FOXP2 TTBK1 GTF3C1 ASXL3 KIAA1217 NAV2 OSBPL10 CTNND2 CEP57 RAI1 | 1.37e-03 | 566 | 165 | 10 | EFO_0007660, EFO_0008354 |
| Disease | diastolic blood pressure, systolic blood pressure | CACNB2 KRT8 ANK3 ADAMTS3 NEK10 CTIF GATA5 SLC45A4 PIEZO2 SLC7A6OS DLEC1 | 1.43e-03 | 670 | 165 | 11 | EFO_0006335, EFO_0006336 |
| Disease | Schizophrenia | SHANK1 DLGAP1 CACNB2 ANK3 FOXP2 ADAMTS3 RIMS3 PTPRA NRXN2 KMT2A DLG1 CTNND2 RAI1 | 1.45e-03 | 883 | 165 | 13 | C0036341 |
| Disease | creatinine measurement | KIF26B SIPA1L3 GATA5 NDRG1 CELSR2 NRXN2 ATXN7 EIF4B PKD2 DLG1 DLEC1 PLEC QSOX2 SORL1 | 1.46e-03 | 995 | 165 | 14 | EFO_0004518 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.50e-03 | 148 | 165 | 5 | C0279702 | |
| Disease | bipolar disorder | SLAIN2 CACNB2 TCF20 ANK3 CLASP1 HUWE1 SLC45A4 PARD6B DLEC1 PLEC | 1.58e-03 | 577 | 165 | 10 | MONDO_0004985 |
| Disease | white matter microstructure measurement | 1.65e-03 | 390 | 165 | 8 | EFO_0005674 | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement | 1.65e-03 | 11 | 165 | 2 | EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 1.65e-03 | 11 | 165 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | aspartate aminotransferase measurement | CACNB2 KRT8 WWC3 CDKN2AIP TBC1D5 BAG3 MUC19 MARCHF7 SLC45A4 WWC2 ROBO1 AKAP13 SMG6 | 1.78e-03 | 904 | 165 | 13 | EFO_0004736 |
| Disease | breast carcinoma | SHANK1 ARHGAP24 CLASP1 PPRC1 NEK10 TBC1D5 LMNB2 EPB41L4A TTBK1 ATXN7 GLI2 PKD2 SMG6 BAHCC1 | 1.82e-03 | 1019 | 165 | 14 | EFO_0000305 |
| Disease | PR interval | 1.95e-03 | 495 | 165 | 9 | EFO_0004462 | |
| Disease | osteoarthritis, knee | 1.99e-03 | 158 | 165 | 5 | EFO_0004616 | |
| Disease | Connective Tissue Diseases | 2.33e-03 | 13 | 165 | 2 | C0009782 | |
| Disease | Charcot-Marie-Tooth disease type 4 | 2.33e-03 | 13 | 165 | 2 | cv:C4082197 | |
| Disease | skin melanoma (is_marker_for) | 2.33e-03 | 13 | 165 | 2 | DOID:8923 (is_marker_for) | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 2.35e-03 | 99 | 165 | 4 | EFO_0004639, EFO_0008595 | |
| Disease | corpus callosum volume measurement | 2.44e-03 | 100 | 165 | 4 | EFO_0010299 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 2.71e-03 | 14 | 165 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 2.71e-03 | 14 | 165 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | cognitive inhibition measurement | 2.78e-03 | 50 | 165 | 3 | EFO_0007969 | |
| Disease | lung adenocarcinoma, family history of lung cancer | 2.94e-03 | 51 | 165 | 3 | EFO_0000571, EFO_0006953 | |
| Disease | Metastatic melanoma | 3.46e-03 | 54 | 165 | 3 | C0278883 | |
| Disease | T-Cell Lymphoma | 3.54e-03 | 16 | 165 | 2 | C0079772 | |
| Disease | insomnia measurement | 3.59e-03 | 443 | 165 | 8 | EFO_0007876 | |
| Disease | Beta blocking agent use measurement | 3.90e-03 | 114 | 165 | 4 | EFO_0009929 | |
| Disease | major depressive disorder (is_implicated_in) | 4.00e-03 | 17 | 165 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | oral motor function measurement | 4.00e-03 | 17 | 165 | 2 | EFO_0021793 | |
| Disease | X-12063 measurement | 4.01e-03 | 186 | 165 | 5 | EFO_0021283 | |
| Disease | irritable bowel syndrome symptom measurement | 4.23e-03 | 58 | 165 | 3 | EFO_0021536 | |
| Disease | macula measurement | 4.30e-03 | 189 | 165 | 5 | EFO_0008375 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 4.41e-03 | 118 | 165 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | platelet-to-lymphocyte ratio | 4.46e-03 | 363 | 165 | 7 | EFO_0008446 | |
| Disease | Tourette syndrome, schizophrenia | 4.48e-03 | 18 | 165 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | neutrophil count | CDC42BPA MARCHF7 CHD7 TULP3 MAP3K5 SLC45A4 EVI5 PTPRA NDRG1 GTF3C1 ATXN7 RP1L1 AKAP13 TNS3 SMG6 FAM43A | 4.78e-03 | 1382 | 165 | 16 | EFO_0004833 |
| Disease | Cleft palate, cleft lip | 4.96e-03 | 279 | 165 | 6 | EFO_0003959, HP_0000175 | |
| Disease | mean reticulocyte volume | DLGAP1 KRT8 CLASP1 PPRC1 SPECC1 TULP3 PTPRA GTF3C1 KIAA1217 AKAP13 LSM11 | 5.47e-03 | 799 | 165 | 11 | EFO_0010701 |
| Disease | sarcopenia | 5.53e-03 | 20 | 165 | 2 | EFO_1000653 | |
| Disease | citrulline measurement | 5.53e-03 | 20 | 165 | 2 | EFO_0009777 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | PDE1C ARPP21 TCF20 FOXP2 TBC1D5 MINK1 CHD7 NRXN2 UTRN SMG6 SORL1 | 5.57e-03 | 801 | 165 | 11 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RSTGSATSLASQGER | 626 | Q5SW79 | |
| TRSTSSAGSNNSAEG | 256 | Q86US8 | |
| NGSISSAGNSSRNSS | 121 | Q9BSF8 | |
| SSGASSQVLEQRAGS | 1226 | Q9P281 | |
| GSRSSSSGSLNARSS | 721 | Q7Z3E2 | |
| AASASSEAGSSRSQE | 6 | O43310 | |
| NSSISSGSGSLRTSQ | 566 | Q12959 | |
| GSSSSNSSGDALVTR | 66 | Q3ZCQ3 | |
| SSCGNRNEETGTKSS | 416 | Q12802 | |
| AGDSSRSTLQSVISG | 131 | Q9BYV8 | |
| EERNSSSRSGITGTT | 446 | Q86XR8 | |
| GNALRTSGSSSSDVT | 306 | Q5M775 | |
| RLSSSSSNDSGNKVG | 5861 | Q09666 | |
| SRDASTSTVSIQGSG | 731 | O14490 | |
| SSSTTNGNRATGSSD | 396 | Q9BSQ5 | |
| ESARAGRSVSTQTGS | 11 | Q9BWV3 | |
| CTGSSRGSSASEGSR | 2861 | Q9HCU4 | |
| SGTRHAETSSRGQTA | 356 | P20930 | |
| DASRGQSGSRSASRT | 881 | P20930 | |
| GQSEGSRTSRRQGSS | 931 | P20930 | |
| ASHGQSGSRSASRQT | 1206 | P20930 | |
| QSSGSRTSRHQGSSV | 1256 | P20930 | |
| SAGSKTSRRQGSSVS | 1581 | P20930 | |
| SSGGQAASSQEQARS | 1661 | P20930 | |
| QQSADSSTDSGTGRR | 1686 | P20930 | |
| SSTDSGTGRRQDSSV | 1691 | P20930 | |
| TTSQERSDVSRGQSG | 1846 | P20930 | |
| QSGTRHTESSSRGQA | 1976 | P20930 | |
| TTSQGRSDASRGQSG | 2171 | P20930 | |
| RSDASRGQSGSRSAS | 2176 | P20930 | |
| DASRGQSGSRSASRT | 2826 | P20930 | |
| SASRTTRNEEQSGDG | 2836 | P20930 | |
| SSRQSGTRHTQTSSG | 2946 | P20930 | |
| SHTTSQGRSDASRGQ | 3141 | P20930 | |
| HTTSQGRSDASRGQS | 3466 | P20930 | |
| SSQHSEGSRSSGSNR | 566 | Q92997 | |
| SDGSTTSTSFILRQG | 36 | O00305 | |
| SAATGNTTTASSQGE | 2821 | Q9P2D1 | |
| RATGQSFSQGTTSRA | 196 | Q9UQB3 | |
| DGSGRTSGSRQSSSE | 336 | Q9UBL0 | |
| RASTSTSVSGGRNTG | 1036 | Q9C0F0 | |
| TSAGSSSGTNSSGQR | 136 | Q9UHB7 | |
| SSGTNSSGQRHDRES | 141 | Q9UHB7 | |
| DGSTSSDTTSNSFVR | 56 | Q08289 | |
| LRSRSSSSSNASGNG | 1241 | Q7Z5J4 | |
| TKNSSGGGESRSSSR | 131 | Q96T37 | |
| LDSGSVRGATANSSA | 66 | Q6ZRP7 | |
| RGSSVSREGSTSSSL | 126 | Q9C0H5 | |
| GSSVGSSASSSATRR | 571 | Q8TB72 | |
| VRNSRTSGSSGQSTD | 256 | Q9BYG5 | |
| NVTSTSGSSGSSRGV | 511 | Q01546 | |
| GAGSSSFSRTSSSRA | 446 | P05787 | |
| EVQTSSSFSSSGGRQ | 31 | Q96LL4 | |
| LFSTGQAARSGSSSS | 3016 | Q8WXI7 | |
| GQSTQTGSRTTGRRS | 1786 | Q5D862 | |
| RSEASNGSTVAAGTS | 241 | A8MTJ6 | |
| RSGSANSASSQAASS | 296 | Q86YD5 | |
| TTRTDGSSVGGTFSR | 301 | P83369 | |
| GSSNDSSARSQERAG | 761 | Q66K74 | |
| SASASRNEGGNSESS | 801 | Q8IWI9 | |
| ATQSSTTGSSTERGS | 251 | A5PLN7 | |
| SGFSSVSVSRSRGSG | 31 | P02538 | |
| TNSESRTTSNGAGTA | 211 | Q5SSG8 | |
| RTTSNGAGTATNSES | 216 | Q5SSG8 | |
| LSSSQFSSGSQSSRD | 426 | P02533 | |
| RATSSSSGSLSATGR | 416 | Q03252 | |
| GRSASVRSEGNTSSL | 46 | Q8TAV5 | |
| DSTSENSSSVGGRCR | 1916 | Q2KJY2 | |
| SAVVSGGSRRSTSSF | 26 | P35908 | |
| ESGNSARSSGISSQN | 186 | Q9NXV6 | |
| RFSGSIDSSSNSASL | 81 | P01721 | |
| HEGGSTSASITRSSQ | 1076 | O15534 | |
| VSSSNGGESSSRSAE | 36 | Q8WW12 | |
| NSSRDSGRGDSVSDS | 66 | Q53EL6 | |
| SFSASGGERQSQTRD | 931 | Q6ZWH5 | |
| QTGSTSTSSSRCDQG | 621 | Q14149 | |
| SLNSVNSSDSRSSGS | 276 | O43312 | |
| RGSIGTESRAESTTS | 6326 | Q7Z5P9 | |
| RATGATTSIAGSDTS | 6441 | Q7Z5P9 | |
| GDRSSTGSESRTATT | 6756 | Q7Z5P9 | |
| ETSQTGGTGQRRSSL | 456 | Q14123 | |
| TSEGTRSRSHTSEGA | 356 | Q92597 | |
| VNGSRRNSGSSLVSS | 106 | O60447 | |
| SRDGRSSGDTSSEVS | 31 | O15409 | |
| QSSRGERHRSSSGSS | 266 | Q86YZ3 | |
| SRSGQSSRGERQGSS | 496 | Q86YZ3 | |
| SSRGERQGSSAGSSS | 501 | Q86YZ3 | |
| SRSGQSSRSEQHGSS | 731 | Q86YZ3 | |
| DASRRSSEASQCSGG | 861 | P10070 | |
| RSAQSAQSSGSVGSS | 146 | Q96CW5 | |
| LQDGLRSSSNSRSGS | 26 | P36915 | |
| NGRLSSSSGSASDRT | 316 | Q86UY5 | |
| TADARGRSGSSSRTN | 166 | Q9ULI3 | |
| EAQANSGSGASSTTT | 3471 | Q7Z6Z7 | |
| RTGSNISGASSDISL | 376 | P22059 | |
| SGSNRSSSGGVLSAS | 201 | O15265 | |
| GNSSRRGSGDTSSLI | 321 | Q9Y608 | |
| RATGGSLSTGNNDTS | 266 | Q9NYA4 | |
| RSGSSFSQRAGSSGN | 411 | A2A3N6 | |
| QSSGSTTSGSRQAAR | 1731 | O95248 | |
| SSSSQDVNGFTDGSR | 821 | O14522 | |
| VANSNTGSGSRRDSL | 696 | Q14671 | |
| TGSGSRRDSLTGSSD | 701 | Q14671 | |
| GAAEGARVSSSLSTT | 46 | P58401 | |
| VGGRSSRATSSSDNS | 616 | Q8N264 | |
| RGSSGSTRNASASPS | 301 | Q9BWX5 | |
| AASDSIGASSQARTS | 1171 | O15072 | |
| GFQNGRGSSTSSSSI | 66 | Q9UJT9 | |
| RTSTETTGGSAQAGQ | 621 | Q2TAC2 | |
| STSRNTSLSETSRGG | 4031 | Q12955 | |
| AGDRASSNPNATSSS | 16 | P05155 | |
| SGISERFSASRSGNT | 76 | A0A075B6I4 | |
| TSATAGDSSRQADGA | 401 | Q8N2R8 | |
| NRPQASAASSSATTG | 446 | Q9H992 | |
| TRSVCSSRSSSSGGG | 141 | A6NNE9 | |
| SEGEASGRTDTSRST | 666 | Q9P0L2 | |
| SSSSEGLARAQGLSS | 351 | Q6ZW76 | |
| RTSAGTSSSGVSNRK | 721 | Q03164 | |
| SSTNGNKEGARSSLS | 91 | A6PVL3 | |
| GSQQSEGSKSSGSTR | 566 | O14640 | |
| QSSSDDTSGSSVARR | 26 | Q96QF7 | |
| NVQSRSGDTSGSSVA | 51 | Q96QF7 | |
| RQNSSSSDSGGSIVR | 656 | Q12929 | |
| RQSSGSSSSGFGASR | 601 | O15523 | |
| GSQQSEGSKSSGSTR | 541 | P54792 | |
| QGASSREGSPARSST | 271 | O95817 | |
| TDSSVEGSSSASNRV | 1351 | Q9Y238 | |
| SRSRCNTSSGSESEN | 476 | Q9HCS5 | |
| NSRSVSSGSNRTSEA | 1426 | Q5VV67 | |
| SSDSDNGTTRTASTN | 81 | P18433 | |
| ERSRTGSESSQTGTS | 416 | P23588 | |
| RTSSIATALNTSGAG | 671 | Q8N4C8 | |
| TSSSSATRGRGSSVG | 71 | Q99683 | |
| RTNGSFLTDSSSTTG | 3206 | P46939 | |
| SGADASATQAARSTD | 2121 | Q92673 | |
| GQGDSRARCDSTSST | 576 | Q684P5 | |
| SSGSSCNSTRRGTFS | 301 | Q9P270 | |
| SSARSTQGTTGIRED | 106 | O60880 | |
| QSSSSSSDGGLFRSR | 451 | Q15750 | |
| TSSARGTQSVSGQDG | 1136 | Q7Z7B0 | |
| SGASRNVVRSSSISG | 11 | Q9UJD0 | |
| RQGSRESTDGSTNSN | 101 | Q9UJD0 | |
| AATTTRNGTGSAAST | 226 | P55318 | |
| DARERGSQSSDSSSS | 1946 | O75376 | |
| KSNSRNGAGNRSSTS | 1221 | Q8IVL1 | |
| NGAGNRSSTSSIDSN | 1226 | Q8IVL1 | |
| RNTTTGASAASAASA | 366 | O60292 | |
| RLSNGNSRGSVSKSS | 46 | Q5T5P2 | |
| GRTLQRTSTSNESGD | 841 | Q9Y6H5 | |
| SSNGPGQRRESSSSA | 931 | Q68CZ2 | |
| SSGLSARSSAQNGSA | 1631 | Q5VT25 | |
| SSGEASSTSRSQGTQ | 181 | Q9NZP6 | |
| SSTSRSQGTQGDVAS | 186 | Q9NZP6 | |
| DGTASTTLRNGSALS | 376 | Q96PQ1 | |
| GGGSNSSSRSSSRAT | 11 | Q9BXB5 | |
| TGSGGVASSSESNRD | 11 | Q15428 | |
| SSSGRSSQGSSTEAE | 1166 | Q9Y566 | |
| SSGSATNVASTPDNR | 646 | Q7Z460 | |
| DRSSNGSSRGSSEEG | 926 | Q15735 | |
| LSSRRSLGTTSSGQE | 106 | Q96CW6 | |
| RNQSGATTSSGDTES | 471 | Q5BKX6 | |
| GSTSNGTRFSASDLT | 351 | Q14186 | |
| SRVSADSQGGRAGSS | 76 | Q96NJ1 | |
| SNLNSSGANRTSLSG | 1176 | Q6ZU65 | |
| SGSSSEGSERSTDRS | 786 | Q5TCY1 | |
| ASGASSSSSEEQRRA | 1106 | Q5TCY1 | |
| LASSRGSLNTSSRGS | 446 | Q6AWC2 | |
| ATEEGSGSFTQSRSS | 246 | Q9NTN9 | |
| SNSTTGTSIGDDSRR | 446 | Q6ZNA4 | |
| GTSIGDDSRRTTSSA | 451 | Q6ZNA4 | |
| GSSSSTRTQASGNLR | 706 | Q8IWN7 | |
| NASCGTRSAGRTTSA | 36 | P60468 | |
| GRSSRDSSAGSDTSL | 701 | Q6SZW1 | |
| QGTSTCSTAGSNSSR | 1336 | Q96MS0 | |
| SNSSRGSSSSRGSRG | 1346 | Q96MS0 | |
| TRNASQGAGSSDTAA | 291 | Q9NVW2 | |
| SDTAASGESTGSGQR | 301 | Q9NVW2 | |
| SNEGSSSSGSSGARR | 496 | Q9NVW2 | |
| VGQGARQDDSSSSAS | 331 | Q6VEQ5 | |
| STQTSSARSRGQEKG | 296 | A7MD48 | |
| VGQGARQDDSSSSAS | 331 | A8K0Z3 | |
| SQRGSTSTRNSSQKG | 2116 | Q9H5I5 | |
| AANSGSNSSGATRAS | 226 | Q5GH76 | |
| GSVESLRSSLSGQSS | 506 | O94885 | |
| DNISSGRSSVSSSDG | 1381 | Q9Y6N7 | |
| NAGGFRSRSSSVGSS | 4376 | Q15149 | |
| RSASSNSAEAGGDTV | 1366 | Q9UGU0 | |
| GSRRSAASSAVSSVG | 121 | Q13563 | |
| AASSAVSSVGARSRG | 126 | Q13563 | |
| SRTNSGISSASGGST | 716 | Q86X10 | |
| QTAGGSSTAREGATS | 1426 | A7E2V4 | |
| SSRSAVSIGGGNTSA | 381 | O95789 | |
| AGSRSSSRENRATSG | 96 | O43247 | |
| SVGSARSSVSSLGSR | 136 | A6NIX2 | |
| RSSVSSLGSRGSAGA | 141 | A6NIX2 | |
| SGGDSNKNGRRTSST | 31 | Q92609 | |
| TGSVGNTRSSSVSRD | 1446 | Q9Y4F4 | |
| SGSGDSQLSASSRSE | 746 | Q12789 | |
| SQSGQTSVGGSTALR | 151 | Q96IQ7 | |
| NSDAGSSTIRRTGSG | 891 | Q68DK2 | |
| QNSTDTGTSGSATAA | 161 | O75386 | |
| NSLSGSSTGSQEQRA | 1216 | Q96J92 | |
| SLASSRGSLASSRGS | 371 | Q9ULE0 | |
| RGSLASSRGSLSSVS | 376 | Q9ULE0 | |
| TSNSNSSRSGSQRQG | 556 | Q9P275 | |
| RGSRGSQIDSHSSNS | 576 | Q5T200 | |
| LNGTSRGSSDLTSAR | 46 | Q9BVV6 | |
| AHSTTSGRGESTTSR | 1206 | Q9UKN1 | |
| AHSTTSGRGESTTSR | 3846 | Q9UKN1 | |
| NTTSGRGEESTTSHS | 4571 | Q9UKN1 | |
| RSSSQRASSQTSLGG | 51 | P54296 |